Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036428	pf-ada	u/l (u/l)	2375	3010	0.17%
3036428	pf-ada	— (—)	261	295	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pyothorax

233

112

24.39

316.28

1.4

1.3

26.70

12.52

u/l

4.59

218

103

COPD differential diagnosis

529

202

13.23

307.65

1.3

1.2

13.13

10.44

u/l

1.06

493

176

Heart failure,strict

701

884

5.85

307.65

1.4

1.2

11.28

15.81

u/l

3.27

613

848

903

1030

5.57

307.65

1.3

15.31

12.29

u/l

2.19

818

964

Heart failure, not strict

814

1101

5.18

307.65

1.3

1.2

11.38

15.80

u/l

4.13

720

1052

Lung cancer and mesothelioma

519

101

46.61

307.65

1.3

1.2

13.32

11.33

u/l

0.37

506

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

549

497

9.70

307.65

1.3

13.27

12.03

u/l

0.74

533

451

Other pulmonary diagnosis

543

202

13.58

307.65

1.3

1.2

13.28

10.42

u/l

1.17

503

176

Excluding asthma or asthma-COPD overlap

531

202

13.28

307.65

1.3

1.2

13.20

10.42

u/l

1.11

495

176

Other pleural conditions

709

109

78.52

307.65

1.4

1.2

13.52

14.39

u/l

0.13

671

ILD differential diagnosis

529

202

13.23

307.65

1.3

1.2

13.13

10.44

u/l

1.06

493

176

Pneumonias (Asthma/COPD co-morbidities)

980

1252

5.49

307.65

1.3

15.25

13.10

u/l

1.16

882

1177

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

978

1268

5.49

307.65

1.3

15.26

13.13

u/l

1.15

880

1193

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

903

1030

5.57

307.65

1.3

15.31

12.29

u/l

2.19

818

964

Pleural effusion

1367

181

96.08

307.65

1.4

1.1

14.33

12.99

u/l

0.34

1320

153

COPD (mode)

315

152

16.77

307.65

1.2

14.27

10.89

u/l

0.81

290

133

All pneumoniae

981

1249

5.49

307.65

1.3

15.14

13.15

u/l

1.04

884

1174

Influenza and pneumonia

974

1222

5.30

307.65

1.3

15.43

13.07

u/l

1.30

877

1150

Other diseases of pleura

1726

524

31.66

307.65

1.4

1.1

14.07

14.78

u/l

0.20

1635

461

Suppurative and necrotic conditions of lower respiratory tract

258

140

20.99

307.65

1.4

1.3

27.42

12.35

u/l

5.21

242

128

Pneumonia, organism unspecified

936

1205

5.70

307.65

1.3

14.96

13.02

u/l

0.98

852

1134

Asthma, unspecified (mode), excluding more controls

283

121

18.52

302.96

1.3

1.1

13.88

11.49

u/l

0.58

256

110

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

423

437

8.40

292.77

1.2

1.3

12.80

11.55

u/l

0.60

410

395

Heart failure, strict

759

1179

4.73

289.12

1.4

1.3

11.08

14.91

u/l

2.92

662

1120

All-cause Heart Failure

737

1161

4.67

276.71

1.4

1.3

11.25

14.92

u/l

2.60

642

1102

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

326

328

9.80

268.46

1.2

1.3

11.52

11.74

u/l

0.08

316

292

Abnormal findings on diagnostic imaging of lung

635

1350

4.68

265.59

1.3

14.29

13.43

u/l

0.34

595

1247

Asthma, unspecified (mode)

296

189

12.52

263.81

1.3

1.2

13.72

10.27

u/l

0.95

268

163

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

715

1601

4.21

258.24

1.4

1.3

14.13

13.31

u/l

0.38

665

1475

Malignant neoplasm of respiratory system and intrathoracic organs

453

699

6.21

250.38

1.3

13.28

13.78

u/l

0.15

440

631

Asthma, excluding more controls

334

127

14.10

242.55

1.3

1.1

13.16

11.87

u/l

0.30

295

116

Other bacterial diseases

825

1543

3.74

231.94

1.3

15.17

13.54

u/l

0.62

743

1442

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

467

756

5.53

228.62

1.2

1.3

13.06

12.54

u/l

0.16

439

684

Later onset COPD, excluding more controls

227

116

15.62

223.40

1.3

1.2

14.25

11.45

u/l

0.47

208

101

Heart failure and antihypertensive medication

351

274

8.67

221.98

1.4

1.3

11.72

16.93

u/l

1.63

307

257

Dyspnoea

789

1690

3.62

218.99

1.4

1.3

13.15

14.24

u/l

0.55

730

1560

Other medical care

505

1061

4.74

215.23

1.3

12.24

13.73

u/l

0.73

473

988

Asthma (only as main-diagnosis), excluding more controls

280

127

13.21

213.53

1.3

1.1

13.26

11.87

u/l

0.32

247

116

Bacterial infection, other or unspecified

583

1260

4.24

211.30

1.3

14.92

13.18

u/l

0.50

536

1176

Diseases of the respiratory system

372

207

9.07

206.73

1.3

1.1

11.56

10.56

u/l

0.33

344

179

Asthma

349

201

9.37

206.62

1.3

1.2

13.48

10.42

u/l

0.92

309

175

Asthma (mode)

327

202

8.94

190.94

1.3

1.2

11.64

10.44

u/l

0.39

292

176

Non-small cell lung cancer

326

544

6.25

187.13

1.2

1.3

11.52

13.56

u/l

0.96

316

488

Asthma (only as main-diagnosis)

294

201

8.87

180.83

1.3

1.2

13.02

10.42

u/l

0.72

260

175

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

157

118

14.21

168.57

1.2

1.3

12.15

10.20

u/l

0.56

149

105

Non-ischemic cardiomyopathy

380

645

4.95

160.19

1.4

1.2

12.25

14.22

u/l

0.58

330

612

Early onset COPD, excluding more controls

142

14.68

158.57

1.2

1.3

13.69

11.96

u/l

0.24

132

Renal tubulo-interstitial diseases

689

1680

3.17

157.11

1.3

12.70

14.01

u/l

0.67

608

1577

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

741

1756

3.05

155.24

1.3

12.80

14.37

u/l

0.80

669

1635

Oxycodone

409

940

4.28

153.41

1.3

11.72

14.38

u/l

2.10

382

862

Abnormalities of breathing

645

1134

3.41

151.32

1.3

1.2

13.48

15.32

u/l

0.82

591

1059

Pneumothorax

112

21.17

148.27

1.3

1.2

13.14

15.06

u/l

0.19

105

Persons encountering health services for specific procedures and health care

740

1516

3.04

148.00

1.3

12.99

14.87

u/l

0.93

669

1412

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

222

317

7.20

147.57

1.2

1.3

11.46

12.01

u/l

0.21

214

282

Renal failure

506

1338

3.52

141.44

1.3

10.27

14.17

u/l

4.25

432

1256

COPD/asthma related infections

673

1030

3.29

141.10

1.3

14.56

12.29

u/l

1.33

617

964

COPD/asthma/ILD related infections

673

1030

3.29

141.10

1.3

14.56

12.29

u/l

1.33

617

964

Other heart diseases, wide

548

955

3.58

140.70

1.3

1.2

12.89

16.05

u/l

1.15

493

909

Non-rheumatic valve diseases

407

718

4.19

135.90

1.4

1.2

11.62

15.69

u/l

1.84

365

688

Malignant neoplasm of bronchus and lung

325

661

4.75

135.70

1.2

1.3

12.60

13.33

u/l

0.22

316

598

Valvular heart disease excluding rheumatic fever

407

720

4.18

135.64

1.4

1.2

11.63

15.68

u/l

1.84

365

690

Bacterial Sepsis

472

1190

3.58

135.00

1.3

13.31

13.57

u/l

0.07

411

1116

Heart failure and bmi 25plus

385

615

4.40

132.94

1.4

1.3

12.77

15.70

u/l

0.79

332

586

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

555

973

3.40

129.61

1.3

14.77

13.37

u/l

0.38

523

879

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

554

972

3.39

129.22

1.3

14.79

13.36

u/l

0.39

522

878

Malignant neoplasm, wide definition for exclusion

554

973

3.39

129.03

1.3

14.79

13.36

u/l

0.39

522

879

Implicit Sepsis

589

1518

3.05

125.98

1.3

13.25

13.65

u/l

0.12

518

1425

Bacterial pneumonia, not elsewhere classified

353

755

4.19

125.91

1.3

15.39

12.23

u/l

1.11

297

714

Bacterial pneumoniae

359

782

4.12

125.04

1.3

15.47

12.20

u/l

1.21

302

741

Non-small cell lung cancer, adenocarcinoma, helper endpoint

157

183

9.13

125.03

1.2

1.3

12.15

15.57

u/l

0.65

149

168

Non-small cell lung cancer, adenocarcinoma

157

183

9.13

125.03

1.2

1.3

12.15

15.57

u/l

0.65

149

168

Implicit bacterial Sepsis

424

1102

3.59

122.38

1.4

1.3

13.31

13.69

u/l

0.09

365

1032

Other heart diseases

276

332

5.53

121.37

1.3

1.2

10.60

20.77

u/l

4.09

245

316

Malignant neoplasm

564

1053

3.20

120.56

1.3

14.82

13.34

u/l

0.42

533

953

Septicaemia

399

1079

3.61

117.98

1.3

14.07

13.36

u/l

0.18

352

1007

Non-invasive ventilation

198

291

6.49

117.52

1.4

1.2

11.66

15.23

u/l

1.28

155

284

Dialysis, with operation codes

191

298

6.62

117.07

1.3

9.01

14.11

u/l

2.54

158

280

Nephropathy related operations

187

298

6.49

112.33

1.4

1.3

8.63

13.93

u/l

2.72

155

276

Pleural plaque

128

134

9.85

109.94

1.3

1.1

13.66

14.18

u/l

0.07

119

112

Explicit Sepsis

403

1149

3.41

109.28

1.3

13.98

13.59

u/l

0.09

356

1076

Acute renal failure

260

583

4.57

106.60

1.4

1.3

10.02

14.16

u/l

2.28

225

540

Any event in cancer register

542

1079

3.00

104.50

1.3

13.50

14.20

u/l

0.22

510

981

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

230

477

4.92

103.58

1.2

1.3

11.08

11.94

u/l

0.51

217

433

Chronic kidney disease

345

977

3.58

101.50

1.4

1.3

10.32

14.36

u/l

2.68

290

915

Oral corticosteroids

702

1681

2.54

100.80

1.3

1.2

14.15

13.53

u/l

0.31

642

1552

Other septicaemia

351

998

3.50

99.83

1.3

13.95

13.46

u/l

0.11

309

928

First line medication for Crohn's disease

683

1444

2.59

98.96

1.3

1.2

15.00

13.94

u/l

0.34

630

1327

Atrial fibrillation and flutter

229

281

5.37

97.26

1.3

1.2

11.04

21.02

u/l

3.02

201

266

Atrial fibrillation and flutter with reimbursement

217

246

5.73

97.13

1.3

1.2

10.89

18.28

u/l

4.88

187

232

Condition for Implicit Sepsis (Organ dysfunction codes)

579

1581

2.68

96.94

1.3

13.10

14.32

u/l

0.41

507

1485

Any gastric operation

407

573

3.58

96.59

1.3

1.2

13.49

14.60

u/l

0.36

375

526

GASTRO-related operations

407

573

3.58

96.59

1.3

1.2

13.49

14.60

u/l

0.36

375

526

Fever of other and unknown origin

414

1269

3.05

93.34

1.3

16.39

13.86

u/l

0.56

379

1190

ILD medications: prednisolone, methylprednisolone, prednisone

688

1578

2.48

92.00

1.3

1.2

14.00

13.67

u/l

0.14

628

1459

Inflammatory bowel disease treatment related agents

707

1689

2.39

87.93

1.3

1.2

15.19

13.61

u/l

0.60

646

1559

ILD medications

683

1580

2.38

83.74

1.3

1.2

15.18

13.70

u/l

0.52

622

1461

Primary_lymphoid and hematopoietic malignant neoplasms

210

481

4.43

83.63

1.3

21.13

12.10

u/l

1.45

194

434

Cardiac arrhythmias

314

594

3.51

80.59

1.3

1.2

10.86

17.28

u/l

3.98

276

562

Non-allergic asthma (mode), excluding more controls

12.64

72.55

1.3

1.1

12.25

u/l

0.00

COPD

411

1266

2.71

72.40

1.2

1.3

14.95

13.50

u/l

0.42

381

1177

Bacterial pneumonia (organism specified)

380

1258

2.78

72.13

1.3

15.55

13.23

u/l

0.78

322

1186

Aplastic and other anaemias

398

1415

2.70

71.85

1.3

13.34

13.55

u/l

0.05

351

1314

Ascites

111

166

6.92

71.03

1.3

10.29

12.34

u/l

0.44

102

155

Diseases of arteries, arterioles and capillaries (FINNGEN)

171

237

5.10

70.92

1.3

1.2

10.25

17.82

u/l

6.84

152

224

Cardiomyopathy

160

340

4.78

70.08

1.3

1.2

11.01

16.10

u/l

1.02

142

323

Care involving dialysis

106

154

7.09

69.60

1.4

1.3

7.65

11.06

u/l

2.62

140

Other chronic obstructive pulmonary disease

394

1231

2.69

68.76

1.2

1.3

13.74

13.58

u/l

0.04

364

1145

Other anaemias

370

1345

2.69

66.49

1.3

12.56

13.62

u/l

0.32

329

1249

Erysipelas

386

1348

2.63

66.25

1.3

14.00

13.40

u/l

0.14

347

1260

Other and unspecified anaemias

366

1338

2.68

65.43

1.3

12.62

13.66

u/l

0.31

325

1242

Benign neoplasm of colon, rectum, anus and anal canal

310

741

3.01

64.04

1.3

12.02

13.49

u/l

0.46

289

670

ILD medications: immunosuppressive drugs

344

1228

2.70

63.03

1.3

1.2

17.50

13.88

u/l

0.86

315

1134

Certain infectious and parasitic diseases

530

1132

2.35

61.76

1.3

13.04

13.35

u/l

0.11

483

1072

Cerebrovascular diseases (FINNGEN)

171

277

4.45

61.66

1.3

1.2

12.01

18.50

u/l

3.31

156

263

COPD, hospital admissions

398

1363

2.50

60.11

1.3

13.83

13.86

u/l

0.01

368

1263

Other chronic obstructive pulmonary disease, including avohilmo

435

1532

2.38

59.25

1.3

13.65

13.68

u/l

0.01

401

1415

COPD, early/later onset

399

1374

2.48

59.21

1.3

13.82

13.84

u/l

0.01

369

1273

Other disorders of fluid, electrolyte and acid-base balance

259

830

3.05

58.85

1.2

11.63

13.52

u/l

0.47

234

759

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

539

1671

2.20

58.70

1.3

12.46

14.78

u/l

1.09

485

1562

Continuous positive airway pressure

145

276

4.58

57.81

1.2

1.3

15.03

16.00

u/l

0.15

136

269

Benign neoplasm: Colon

277

728

2.94

56.04

1.4

1.3

10.76

12.93

u/l

1.10

257

659

Covid-19 confirmed case

217

679

3.23

55.09

1.3

16.16

13.30

u/l

0.36

204

619

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

116

232

5.09

54.71

1.3

29.19

10.97

u/l

1.75

107

205

Metabolic disorders

548

1601

2.14

54.21

1.3

14.17

14.30

u/l

0.03

503

1482

Asthma-related pneumonia

288

1068

2.72

53.76

1.3

14.15

13.36

u/l

0.17

250

988

Asthma-related pneumonia or sepsis

288

1069

2.72

53.65

1.3

14.15

13.36

u/l

0.17

250

989

Asthma, hospital admissions 3, pneumonia

288

1069

2.72

53.65

1.3

14.15

13.36

u/l

0.17

250

989

Haemorrhage from respiratory passages

264

863

2.87

53.54

1.3

1.2

12.03

14.17

u/l

0.96

239

811

Polyarthropathies

447

1305

2.30

53.43

1.3

16.28

13.53

u/l

0.76

407

1212

Non-allergic asthma (mode)

8.13

53.14

1.3

12.25

10.53

u/l

0.28

Extracorporeal dialysis

134

6.64

53.00

1.4

1.2

7.37

12.22

u/l

2.12

125

Implicit viral Sepsis

165

447

3.74

52.50

1.3

13.39

12.69

u/l

0.10

148

417

Viral Sepsis

165

447

3.74

52.50

1.3

13.39

12.69

u/l

0.10

148

417

Other arrhythmias

303

869

2.68

52.09

1.3

1.2

14.08

15.69

u/l

0.47

271

829

Bleeding

525

1836

2.09

51.06

1.3

12.84

14.19

u/l

0.48

474

1703

COPD, hospital admission 2, with asthma infections

303

996

2.63

50.88

1.2

1.3

13.91

13.81

u/l

0.02

277

915

Transplanted organ and tissue status

168

5.71

50.26

1.3

7.83

13.84

u/l

3.85

155

COPD related to multimorbidity

349

1224

2.43

49.62

1.3

13.71

13.55

u/l

0.04

321

1129

Conduction disorders

200

513

3.27

49.53

1.3

1.2

11.63

15.66

u/l

1.20

177

491

Cardiovascular diseases (excluding rheumatic etc)

208

353

3.41

49.19

1.2

11.72

20.73

u/l

3.75

191

337

Codes for special purposes

266

993

2.70

49.10

1.3

16.07

14.03

u/l

0.30

248

915

Provisional assignment of new diseases of uncertain etiology

265

991

2.69

48.75

1.3

16.11

14.05

u/l

0.30

247

913

All influenza

155

423

3.70

48.72

1.4

1.3

16.14

12.10

u/l

0.68

141

404

Pulmonary heart disease, diseases of pulmonary circulation

261

977

2.70

48.05

1.3

10.93

14.24

u/l

2.63

241

897

Presence of cardiac and vascular implants and grafts

379

1247

2.32

47.78

1.4

1.3

9.92

14.14

u/l

3.00

335

1169

Infections, IBD-co-morbidities

134

227

4.35

47.30

1.4

1.2

18.33

12.87

u/l

1.58

120

217

Tramadol

420

1210

2.24

47.23

1.3

12.10

15.11

u/l

2.20

389

1113

Cardiomyopathy (excluding other)

111

243

4.64

47.06

1.2

11.77

16.63

u/l

0.58

226

Valvular operations

121

285

4.31

46.75

1.4

1.2

12.92

16.39

u/l

0.49

116

267

AV-block

146

352

3.82

46.57

1.4

1.2

12.07

15.79

u/l

0.70

128

334

Primary_lymphoid and hematopoietic malignant neoplasms

210

713

2.99

46.53

1.3

21.13

13.07

u/l

1.21

194

648

Cardiomyopathies, Primary/intrinsic

107

230

4.73

46.39

1.2

12.00

16.36

u/l

0.48

215

Neoplasms

313

645

2.61

46.18

1.3

13.44

15.18

u/l

0.72

293

582

COPD, hospital admissions 3, with asthma pneumonia sepsis

269

874

2.65

46.02

1.2

1.3

13.93

13.69

u/l

0.05

244

803

Glomerular disorders in diseases classified elsewhere

122

294

4.23

45.85

1.4

1.3

10.77

13.90

u/l

0.70

104

273

ILD, hospital admission 2, with pulmonary infections

187

5.13

44.73

1.3

15.70

12.23

u/l

0.66

177

L04AD Calcineurin inhibitors

162

5.46

44.51

1.3

9.45

11.33

u/l

0.95

153

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

176

322

3.48

44.30

1.3

1.2

14.87

20.06

u/l

0.80

151

307

Opioids

490

1233

2.09

44.29

1.2

1.3

11.95

15.41

u/l

2.95

452

1135

ILD, hospital admissions 3, with pneumonia sepsis

171

5.33

44.09

1.3

15.75

12.80

u/l

0.48

162

Viral pneumonia

193

4.99

44.03

1.4

1.3

10.52

12.59

u/l

0.74

186

Codeine

468

1221

2.11

43.89

1.3

13.56

15.31

u/l

0.64

428

1125

Heart failure and coronary heart disease

326

1029

2.39

43.64

1.4

1.3

10.32

13.58

u/l

1.46

284

957

Diseases of arteries, arterioles and capillaries

466

1707

2.05

43.29

1.3

11.13

13.95

u/l

1.77

413

1590

Chronic lower respiratory diseases

619

1771

1.90

43.02

1.3

14.33

14.13

u/l

0.05

559

1643

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

111

261

4.31

43.01

1.3

18.20

11.68

u/l

0.95

104

231

General symptoms and signs

556

1411

1.98

42.89

1.3

13.76

14.10

u/l

0.10

504

1323

Malaise and fatigue

313

1113

2.36

42.06

1.2

1.3

12.73

13.52

u/l

0.28

278

1046

Other CVD (FINNGEN)

129

5.45

41.17

1.2

16.21

15.83

u/l

0.02

121

Glomerular diseases

159

495

3.26

40.95

1.4

1.3

11.42

12.99

u/l

0.40

134

461

Pulmonary embolism

228

866

2.66

40.88

1.3

11.46

13.90

u/l

1.48

210

791

Complications of surgical and medical care, not elsewhere classified

533

2002

1.92

40.82

1.3

13.11

14.06

u/l

0.32

487

1852

Pulmonary heart disease

228

871

2.65

40.42

1.3

11.46

13.53

u/l

1.19

210

796

Acute tubulo-interstitial nephritis

352

1438

2.18

39.97

1.3

14.98

13.77

u/l

0.33

318

1353

Symptoms and signs involving the circulatory and respiratory systems

464

1135

2.06

39.59

1.3

1.2

11.82

15.33

u/l

2.95

421

1060

Parasetamol

390

912

2.19

39.15

1.3

1.2

14.71

14.01

u/l

0.20

360

851

In situ neoplasms

182

596

2.93

39.05

1.2

1.3

13.23

11.51

u/l

0.43

170

535

Any reimbursement code in KELA

171

251

3.42

38.59

1.3

1.2

12.09

18.34

u/l

4.13

158

233

Hypertensive diseases (excluding secondary)

181

334

3.16

38.34

1.3

1.2

12.31

20.51

u/l

2.88

163

318

DVT of lower extremities and pulmonary embolism

301

1347

2.25

37.36

1.3

11.85

13.74

u/l

1.30

274

1238

Non-follicular lymphoma, hilmo, excluding all cancers

163

5.00

37.07

1.3

32.69

10.48

u/l

1.40

145

Cardiovascular diseases

171

291

3.21

36.30

1.3

1.2

12.15

19.62

u/l

5.81

158

278

Venous thromboembolism

360

1699

2.07

36.26

1.3

11.92

13.72

u/l

1.43

324

1572

Iron deficiency anaemia

276

1199

2.30

36.17

1.3

14.16

13.45

u/l

0.11

242

1108

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

279

811

2.36

36.06

1.2

1.3

16.82

12.54

u/l

0.77

258

731

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

155

311

3.27

36.02

1.2

1.3

11.50

11.85

u/l

0.09

143

267

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

155

311

3.27

36.02

1.2

1.3

11.50

11.85

u/l

0.09

143

267

Hypertensive heart and/or renal disease

208

608

2.68

35.77

1.2

10.79

14.90

u/l

1.85

185

579

Paroxysmal tachycardia

106

225

4.01

35.76

1.3

1.2

8.34

17.89

u/l

10.17

216

Diabetic nephropathy, excluding more controls

130

317

3.48

35.38

1.3

10.72

13.95

u/l

0.91

111

300

Pacemaker

281

1219

2.26

35.33

1.4

1.3

10.10

13.69

u/l

1.57

248

1120

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

108

198

4.08

35.30

1.3

1.2

14.24

12.67

u/l

0.29

189

Asthma, hospital admission 2, infections

327

1534

2.11

34.73

1.2

1.3

14.08

13.46

u/l

0.15

289

1423

Asthma-related infections

327

1534

2.11

34.73

1.2

1.3

14.08

13.46

u/l

0.15

289

1423

Hypertension, essential

360

973

2.12

34.48

1.3

1.2

13.19

16.20

u/l

1.13

329

919

Autoimmune diseases excluding thyroid diseases, strict definition

531

1607

1.85

34.47

1.3

16.95

13.54

u/l

1.19

479

1496

Autoimmune diseases excluding thyroid diseases

544

1660

1.82

33.97

1.3

16.91

13.49

u/l

1.24

488

1544

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

6.11

33.82

1.2

9.27

11.07

u/l

0.67

Pain in throat and chest

377

1129

2.05

33.68

1.3

1.2

13.95

15.20

u/l

0.33

341

1054

Other respiratory disorders and diseases

177

655

2.74

33.59

1.4

1.3

14.26

13.18

u/l

0.17

156

601

Other diseases of the respiratory system

177

655

2.74

33.59

1.4

1.3

14.26

13.18

u/l

0.17

156

601

Gout

242

944

2.36

33.20

1.3

13.70

14.14

u/l

0.05

217

876

Hypo-osmolality and hyponatraemia

136

437

3.14

33.12

1.2

1.3

10.75

12.21

u/l

0.54

121

400

Type 2 diabetes, wide definition

456

1584

1.88

32.64

1.3

11.04

14.56

u/l

4.21

414

1474

Benign neoplasms

280

694

2.29

32.25

1.3

14.83

14.87

u/l

0.00

261

626

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

255

756

2.33

31.94

1.3

18.43

12.48

u/l

1.07

237

682

Complications of procedures, not elsewhere classified

421

1952

1.87

31.23

1.3

13.72

13.65

u/l

0.02

385

1805

Other and unspecified iron deficiency

212

886

2.41

31.19

1.3

15.18

12.91

u/l

0.35

190

815

Chronic periapical parodontitis

148

519

2.88

31.08

1.3

16.55

12.63

u/l

0.64

136

483

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

10.92

30.54

1.2

9.97

9.35

u/l

0.16

Later onset COPD

261

928

2.23

30.51

1.3

13.83

13.76

u/l

0.01

241

848

Disorders of lipoprotein metabolism and other lipidaemias

455

1556

1.85

30.38

1.3

13.96

14.37

u/l

0.12

416

1439

Dentinal caries

152

545

2.80

30.30

1.3

17.99

12.86

u/l

0.79

144

505

Gout, FINNGEN

242

1089

2.25

30.10

1.3

13.70

14.00

u/l

0.03

217

1003

Allergic asthma (mode)

6.43

29.81

1.3

12.20

11.91

u/l

0.03

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

246

747

2.28

29.67

1.2

1.3

15.80

12.51

u/l

0.99

230

673

L04AA Selective immunosuppressants

127

420

3.05

29.62

1.3

15.17

12.15

u/l

0.87

117

389

Nutritional anaemias

307

1480

2.03

29.49

1.4

1.3

13.58

13.32

u/l

0.04

269

1370

Secondary uncertain malignant neoplasm

116

366

3.22

29.41

1.3

17.72

11.87

u/l

0.89

110

334

Explicit bacterial Sepsis

233

3.83

29.17

1.1

1.3

16.42

12.08

u/l

0.39

215

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

246

752

2.26

29.03

1.3

15.77

12.46

u/l

1.00

230

678

Dental caries

160

602

2.65

28.77

1.4

1.3

17.81

12.68

u/l

0.85

152

557

Secondary hypertension

6.22

28.76

1.2

11.47

15.62

u/l

1.11

Cardiodefibrillation

273

1315

2.09

28.44

1.3

9.73

14.69

u/l

6.75

256

1211

Other diseases of blood and blood-forming organs, wide

150

557

2.72

28.33

1.3

15.11

12.45

u/l

0.41

141

511

Operations 2 for CAVS

247

1129

2.16

27.94

1.4

1.3

13.71

13.00

u/l

0.11

222

1031

Calcific aortic valvular stenosis, diagnosis (helper)

247

1129

2.16

27.94

1.4

1.3

13.71

13.00

u/l

0.11

222

1031

Calcific aortic valvular stenosis, operated

247

1130

2.16

27.88

1.4

1.3

13.71

13.04

u/l

0.10

222

1032

Calcific aortic valvular stenosis

247

1130

2.16

27.88

1.4

1.3

13.71

13.04

u/l

0.10

222

1032

Calcific aortic valvular stenosis, including rheumatic fever

247

1130

2.16

27.82

1.4

1.3

13.71

13.01

u/l

0.11

222

1032

Complications of medical and surgical care

385

1994

1.84

27.64

1.4

1.3

12.23

13.78

u/l

0.57

348

1849

Diseases of oesophagus, stomach and duodenum

526

1864

1.72

27.63

1.3

13.22

14.38

u/l

0.39

474

1732

Streptococcal septicaemia

196

4.00

27.04

1.1

1.3

17.64

14.98

u/l

0.17

182

Adjustment and management of implanted device

142

529

2.72

26.71

1.3

9.02

14.39

u/l

3.57

132

487

Peripheral artery disease

326

1362

1.94

26.62

1.3

9.77

14.07

u/l

4.52

283

1270

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

235

3.67

26.50

1.2

1.3

15.13

11.00

u/l

0.67

207

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

217

756

2.25

26.10

1.3

13.04

12.50

u/l

0.12

194

682

Disorders of lens

387

1326

1.85

26.10

1.3

11.23

14.09

u/l

2.63

345

1234

Codeine or tramadol medication

559

1865

1.66

25.62

1.3

13.48

14.16

u/l

0.26

513

1728

Gout, idiopatic and unspecified

198

879

2.28

25.56

1.4

1.3

9.91

14.58

u/l

2.85

179

810

Other acute lower respiratory infections

293

1436

1.96

25.40

1.3

13.64

13.57

u/l

0.02

272

1323

Hypertensive diseases

333

980

1.93

24.94

1.3

1.2

13.46

16.17

u/l

0.90

303

926

Pure hypercholesterolaemia

401

1508

1.79

24.79

1.3

13.70

14.35

u/l

0.23

366

1393

Hypertensive Heart Disease

172

585

2.43

24.70

1.2

11.34

14.88

u/l

1.20

155

556

Hypertension

332

980

1.92

24.64

1.3

1.2

13.47

16.17

u/l

0.89

302

926

Diseases of pulp and periapical tissues

195

873

2.25

24.59

1.3

15.13

13.82

u/l

0.21

181

805

Insulin medication

338

1565

1.86

24.51

1.4

1.3

11.46

14.61

u/l

2.24

297

1454

Other disorders of skin and subcutaneous tissue

367

1888

1.79

23.92

1.3

12.00

13.74

u/l

1.02

325

1760

Diabetic nephropathy

131

495

2.65

23.40

1.3

10.66

13.22

u/l

0.65

112

458

L04AX Other immunosuppressants

256

1304

1.97

22.96

1.3

19.74

13.21

u/l

1.47

238

1208

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

148

4.19

22.89

1.4

1.3

9.47

10.67

u/l

0.37

129

COPD-related respiratory insufficiency

110

390

2.86

22.87

1.3

11.89

13.28

u/l

0.22

354

Hernia of abdominal wall, postoperative

244

3.38

22.86

1.3

1.2

15.38

14.83

u/l

0.07

222

Hyperkalaemia

140

4.31

22.85

1.3

1.2

7.15

13.15

u/l

5.38

128

Gout, strict definition

150

625

2.43

22.50

1.4

1.3

9.37

14.53

u/l

2.36

134

568

Senile cataract

364

1262

1.80

22.41

1.3

12.25

13.93

u/l

0.78

322

1172

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

115

422

2.76

22.39

1.4

1.3

15.68

13.34

u/l

0.23

106

387

Second line medication for Crohn's disease

259

1337

1.94

22.36

1.3

19.69

13.31

u/l

1.44

241

1237

Fall on same level

519

1778

1.63

22.33

1.3

14.59

14.39

u/l

0.05

460

1658

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

201

3.63

22.20

1.2

1.3

16.25

10.66

u/l

0.83

177

Atherosclerosis, excluding cerebral and coronary sclerosis

303

1309

1.86

21.97

1.3

9.86

13.85

u/l

4.03

263

1220

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

104

288

2.94

21.90

1.2

1.3

11.87

11.77

u/l

0.02

248

STROKE

288

1057

1.90

21.63

1.3

11.83

14.70

u/l

1.11

254

992

Unspecified kidney failure

282

3.13

21.23

1.3

8.28

14.57

u/l

3.13

256

Other respiratory diseases principally affecting the interstitium

141

587

2.43

21.20

1.3

14.17

13.35

u/l

0.16

122

535

Ulcer of lower limb, not elsewhere classified

110

407

2.74

21.10

1.4

1.3

10.17

12.79

u/l

1.01

100

368

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

316

1767

1.79

20.99

1.3

11.94

13.68

u/l

0.58

289

1634

Serous carcinoma of ovary

6.76

20.92

1.2

1.1

9.97

11.67

u/l

0.62

COPD, hospital admissions 1, only main diagnosis

258

1153

1.92

20.78

1.2

1.3

13.70

13.76

u/l

0.01

241

1060

530

1755

1.60

20.65

1.3

13.91

13.50

u/l

0.15

490

1631

Injuries to the head

500

2037

1.60

20.58

1.3

15.11

13.82

u/l

0.45

450

1891

Enterocolitis due to Clostridium difficile

277

3.11

20.54

1.4

1.3

11.96

12.98

u/l

0.14

253

Oedema, not elsewhere classified

175

804

2.18

20.53

1.4

1.3

11.02

13.74

u/l

1.13

155

753

Intestinal infectious diseases

431

2041

1.65

20.49

1.3

13.85

14.16

u/l

0.09

381

1899

Other bacterial intestinal infections

117

454

2.60

20.40

1.4

1.3

12.79

12.07

u/l

0.14

103

419

Antihypertensive medication - note that there are other indications

164

380

2.37

20.39

1.2

12.56

18.24

u/l

2.75

151

360

Bronchitis

496

2037

1.60

20.35

1.3

13.34

14.19

u/l

0.43

461

1877

Diseases of liver

187

893

2.11

20.17

1.4

1.3

14.43

13.76

u/l

0.09

170

822

Enlarged lymph nodes

333

2.88

20.14

1.3

13.31

12.64

u/l

0.15

313

Gout, unspecified

159

716

2.25

19.98

1.4

1.3

9.86

14.50

u/l

2.12

144

658

ILD, hospital admissions

120

478

2.54

19.89

1.3

14.75

12.70

u/l

0.43

108

437

Care involving use of rehabilitation procedures

271

1401

1.84

19.76

1.3

1.2

14.51

14.74

u/l

0.04

227

1304

Benign neoplasm: Ascending colon

222

3.32

19.76

1.6

1.3

8.01

11.53

u/l

2.85

194

Disorders of choroid and retina

432

1930

1.64

19.70

1.3

12.45

13.80

u/l

0.53

390

1788

Hard cardiovascular diseases

409

1578

1.67

19.70

1.3

11.95

14.68

u/l

1.33

370

1470

Cardiomyopathy, other and unspecified

130

4.13

19.63

1.5

1.2

16.40

14.07

u/l

0.10

125

Asthma/COPD (KELA code 203)

413

1769

1.65

19.41

1.3

13.85

14.14

u/l

0.07

373

1642

Cough

182

835

2.10

19.41

1.3

1.2

11.70

14.32

u/l

1.63

159

782

Diarrhoea and gastroenteritis of presumed infectious origin

316

1646

1.75

19.27

1.3

14.16

14.42

u/l

0.06

279

1530

Asthma (diagnoses ohter than nonallergic)

398

2076

1.64

19.09

1.3

13.17

14.12

u/l

0.30

358

1925

Other interstitial pulmonary diseases

120

488

2.49

19.06

1.3

14.75

13.39

u/l

0.24

108

446

Interstitial lung disease endpoints

120

489

2.48

18.98

1.3

14.75

13.35

u/l

0.25

108

448

Interstitial lung disease

120

489

2.48

18.98

1.3

14.75

13.35

u/l

0.25

108

448

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

129

249

2.61

18.97

1.3

1.2

12.74

15.05

u/l

0.58

117

236

Glucagon-like peptide-1 (GLP-1) analogues

329

1576

1.73

18.75

1.3

11.71

13.59

u/l

1.55

297

1458

Diseases of the digestive system

269

1488

1.81

18.72

1.4

1.3

13.09

13.75

u/l

0.11

241

1379

Cerebrovascular diseases

412

1813

1.63

18.71

1.3

11.06

14.02

u/l

3.00

365

1686

Chronic periodontitis, complicated

215

3.30

18.70

1.3

14.23

12.39

u/l

0.41

197

Other diseases of the digestive system

213

1097

1.96

18.69

1.4

1.3

13.70

14.01

u/l

0.04

190

1015

Coronary atherosclerosis

377

1453

1.68

18.63

1.3

11.90

14.15

u/l

1.02

344

1347

Iron deficiency anaemia secondary to blood loss (chronic)

106

411

2.60

18.57

1.3

13.99

11.93

u/l

0.22

381

Kidney transplant status

4.96

18.54

1.3

1.2

7.30

11.16

u/l

2.45

Insulin, fast-acting

195

976

2.01

18.51

1.4

1.3

11.10

14.59

u/l

1.66

168

897

Hyperlipidaemia, other/unspecified

238

1204

1.88

18.50

1.4

1.3

12.35

13.40

u/l

0.25

219

1116

Insulin, combination of fast acting with intermediate-acting or long-acting

338

1844

1.70

18.48

1.4

1.3

11.46

14.09

u/l

2.04

297

1713

Bacterial intestinal infections, IBD co-morbidities

115

465

2.49

18.45

1.4

1.3

12.71

12.55

u/l

0.02

102

424

Infections of the skin and subcutaneous tissue

259

1419

1.82

18.45

1.3

14.73

14.54

u/l

0.03

238

1305

GI-bleeding

215

1116

1.94

18.44

1.4

1.3

13.66

13.98

u/l

0.04

192

1032

Volume depletion

233

3.17

18.32

1.2

9.14

13.17

u/l

2.10

213

Non-follicular lymphoma

270

3.01

18.27

1.3

32.69

12.09

u/l

1.25

247

ILD, hospital admissions 1, main diag only

108

427

2.56

18.23

1.3

15.40

12.63

u/l

0.57

390

Use of hypnotics and sedatives

500

1854

1.56

18.17

1.2

1.3

14.88

14.01

u/l

0.28

458

1718

Reimbursement for rheumatic diseases

268

1494

1.80

18.17

1.3

16.02

13.23

u/l

1.76

250

1374

Disorders resulting from impaired renal tubular function

5.13

18.17

1.2

8.61

11.09

u/l

0.65

Diseases of the skin and subcutaneous tissue

472

1487

1.60

18.12

1.3

12.49

14.62

u/l

1.43

434

1381

Early onset COPD

142

636

2.25

18.09

1.2

1.3

13.69

12.85

u/l

0.17

132

589

Insulin, intermediate and long-acting

302

1717

1.73

18.00

1.4

1.3

10.89

14.16

u/l

2.77

263

1598

Chronic periodontitis

106

418

2.56

17.97

1.2

1.3

12.35

12.83

u/l

0.11

391

305

1632

1.72

17.66

1.3

14.70

14.72

u/l

0.00

283

1507

Substance abuse, excluding more controls

288

1444

1.75

17.57

1.2

1.3

15.25

14.20

u/l

0.24

269

1339

Symptoms and signs involving the urinary system

394

1887

1.62

17.53

1.3

13.66

13.61

u/l

0.02

364

1738

Autoimmune diseases

505

1662

1.56

17.50

1.3

16.14

13.49

u/l

0.72

456

1546

Diabetes mellitus

444

1675

1.59

17.30

1.3

11.57

14.65

u/l

3.10

405

1555

Acute bronchitis

220

1154

1.88

17.14

1.3

13.59

13.72

u/l

0.03

208

1058

Diabetes, varying definitions

443

1677

1.58

17.11

1.3

11.52

14.65

u/l

3.17

404

1557

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

431

1660

1.59

17.05

1.3

11.50

14.64

u/l

2.77

392

1540

Hypokalaemia

238

3.06

17.04

1.2

1.3

16.95

11.88

u/l

0.38

217

Unspecified acute lower respiratory infection

336

2.70

17.03

1.2

1.3

13.48

14.15

u/l

0.13

309

Peripheral arterial reconstruction

139

635

2.21

16.95

1.3

9.46

14.30

u/l

3.69

117

580

Other CVD

137

623

2.22

16.87

1.2

1.3

13.59

13.85

u/l

0.03

120

564

Benign neoplasm of colon, rectum, anus and anal canal

344

1891

1.65

16.86

1.3

11.81

13.63

u/l

0.79

322

1742

Non-small cell lung cancer, squamous, helper endpoint

175

3.45

16.77

1.2

1.3

9.27

15.64

u/l

1.73

163

Non-small cell lung cancer, squamous

175

3.45

16.77

1.2

1.3

9.27

15.64

u/l

1.73

163

Benign neoplasm: Colon, unspecified

117

496

2.36

16.75

1.5

1.3

10.58

11.80

u/l

0.55

103

454

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

255

2.92

16.72

1.2

1.3

10.37

10.56

u/l

0.04

216

Invasive ventilation

171

3.44

16.59

1.3

10.86

14.39

u/l

0.68

158

Other retinal disorders

350

1720

1.64

16.56

1.3

11.49

13.74

u/l

1.86

313

1592

Emphysema

196

3.27

16.55

1.2

1.3

19.98

12.88

u/l

0.57

181

Insulin, fast-acting or short human

196

1023

1.92

16.55

1.4

1.3

11.15

14.50

u/l

1.59

169

941

Disorders of gallbladder, biliary tract and pancreas

473

1986

1.54

16.45

1.3

13.17

13.72

u/l

0.18

429

1838

All influenza (not pneumonia)

202

3.19

16.35

1.3

15.68

12.88

u/l

0.50

196

Diabetes, insulin treatment (Kela reimbursement)

464

1840

1.55

16.34

1.3

11.63

14.60

u/l

2.57

422

1709

Abnormal findings on examination of blood, without diagnosis

279

1521

1.73

16.30

1.3

12.35

14.21

u/l

1.19

247

1415

Mental and behavioural disorders due to psychoactive substance use

295

1648

1.69

16.23

1.2

1.3

15.16

14.61

u/l

0.11

276

1520

309

1657

1.68

16.17

1.3

14.68

u/l

0.00

287

1530

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

204

3.18

16.16

1.4

1.3

12.79

13.41

u/l

0.09

189

Alcohol use disorder, Swedish definition

289

1583

1.70

16.08

1.3

14.73

14.62

u/l

0.02

268

1460

Persons encountering health services in other circumstances, wide

551

1920

1.49

15.92

1.3

13.29

14.31

u/l

0.36

521

1756

Substance abuse

288

1629

1.70

15.91

1.2

1.3

15.25

14.69

u/l

0.11

269

1503

Other disorders of kidney and ureter

332

2.65

15.83

1.3

10.63

12.97

u/l

0.69

304

Ischemic heart diseases

389

1532

1.60

15.73

1.3

12.60

14.72

u/l

0.81

355

1419

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

4.94

15.72

1.2

1.3

10.28

10.16

u/l

0.02

Used for control exclusion in common control thyroid runs

471

1553

1.54

15.71

1.3

14.52

13.69

u/l

0.25

430

1444

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

140

661

2.13

15.70

1.3

20.34

11.93

u/l

4.75

130

609

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

457

1949

1.53

15.58

1.3

12.93

14.25

u/l

0.53

412

1808

Fungal Sepsis

4.66

15.46

1.3

1.2

12.86

13.99

u/l

0.13

Benign neoplasm: Rectum, anus and anal canal

379

2.50

15.25

1.3

12.65

11.61

u/l

0.14

341

Type 2 diabetes

432

1663

1.55

15.16

1.3

11.78

14.57

u/l

2.56

393

1543

Seropositive rheumatoid arthritis

142

683

2.09

15.08

1.2

1.3

20.37

12.14

u/l

4.46

132

632

Seropositive rheumatoid arthritis, wide

142

685

2.09

15.07

1.2

1.3

20.37

11.91

u/l

4.92

132

631

Malignant melanoma, excluding all cancers (controls excluding all cancers)

312

2.65

15.00

1.3

10.44

11.59

u/l

0.48

279

Other/unspecified seropositive rheumatoid arthritis

140

678

2.08

14.72

1.2

1.3

20.34

11.96

u/l

4.75

130

625

Amputation

310

2.65

14.69

1.4

1.3

9.54

15.04

u/l

1.99

284

Vocal cord dysfunction

189

3.06

14.62

1.5

1.2

12.84

13.21

u/l

0.10

183

Alcoholic liver disease

272

2.75

14.54

1.3

19.25

14.19

u/l

0.34

254

Rheumatoid arthritis

176

840

1.91

14.47

1.3

19.63

12.91

u/l

3.54

166

778

Endocrine, nutritional and metabolic diseases

308

939

1.67

14.42

1.3

13.18

15.66

u/l

0.77

286

879

Abnormal findings on diagnostic imaging of other body structures

235

2.88

14.33

1.5

1.3

12.43

11.98

u/l

0.10

217

Implicit fungal Sepsis

4.57

14.30

1.4

1.2

11.58

13.91

u/l

0.31

Benign neoplasm: Rectum

320

2.58

14.28

1.3

12.30

11.92

u/l

0.04

287

Convulsions, not elsewhere classified

107

466

2.28

14.19

1.3

18.86

14.40

u/l

0.44

436

Bronchiectasis

200

3.04

14.10

1.4

1.3

19.92

12.17

u/l

0.61

187

Malignant neoplasm of skin

359

1729

1.57

14.07

1.3

14.32

13.11

u/l

0.41

335

1593

Glomerulonephritis

216

2.95

14.06

1.4

1.3

14.59

14.19

u/l

0.03

199

Nausea and vomiting

131

619

2.09

14.03

1.3

13.85

12.37

u/l

0.28

115

572

Lung transplant status

25.55

14.01

1.1

9.32

13.75

u/l

—

Lung transplantation

25.54

14.01

1.1

9.32

13.75

u/l

—

Idiopathic gout

290

2.66

13.92

1.4

1.3

10.04

14.28

u/l

1.55

267

Ischaemic heart disease, wide definition

378

1524

1.56

13.87

1.3

12.69

14.63

u/l

0.69

343

1413

Other cataract

233

1042

1.74

13.70

1.3

12.97

13.38

u/l

0.10

218

973

Acute peritonitis

153

3.32

13.56

1.3

1.2

10.16

12.36

u/l

0.67

142

Other disorders of teeth and supporting structures

116

541

2.16

13.50

1.4

1.3

13.80

12.25

u/l

0.33

106

502

Amputation of toe

200

3.00

13.49

1.3

10.36

14.98

u/l

0.99

188

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

277

1700

1.63

13.47

1.3

12.14

13.71

u/l

0.43

253

1569

Other diseases of intestines

441

1714

1.50

13.44

1.3

14.64

14.35

u/l

0.08

401

1591

Myocardial infarction

292

1292

1.63

13.29

1.3

12.54

14.15

u/l

0.46

257

1197

Type 1 diabetes, wide definition, subgroup 1

404

2.34

13.27

1.3

9.44

14.07

u/l

2.57

373

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

5.84

13.25

1.1

1.2

12.21

9.32

u/l

0.64

Osteopathies and chondropathies

246

1396

1.68

13.15

1.3

12.57

13.35

u/l

0.34

214

1287

Fracture of femur

164

797

1.89

13.03

1.2

1.3

13.79

13.33

u/l

0.06

151

723

Hypotension

113

530

2.15

13.01

1.2

1.3

15.18

13.90

u/l

0.11

478

Open wound of head

255

1530

1.65

12.81

1.2

1.3

13.83

14.25

u/l

0.10

234

1419

Major coronary heart disease event excluding revascularizations

364

1645

1.53

12.73

1.3

13.04

13.71

u/l

0.15

320

1535

Constipation

411

1981

1.49

12.67

1.3

13.08

13.68

u/l

0.20

370

1835

Diabetes medication

433

1779

1.48

12.66

1.3

11.77

14.53

u/l

2.52

392

1650

Mental and behavioural disorders due to alcohol, excluding acute intoxication

225

1331

1.70

12.64

1.3

15.12

14.94

u/l

0.03

210

1229

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

281

2.58

12.59

1.3

9.85

11.34

u/l

0.48

250

Persons with potential health hazards related to communicable diseases

112

525

2.12

12.57

1.2

19.02

13.55

u/l

0.66

100

489

Symptoms and signs involving cognition, perception, emotional state and behaviour

426

2027

1.48

12.52

1.3

14.41

13.88

u/l

0.14

387

1883

Polyneuropathies and other disorders of the peripheral nervous system

134

680

1.99

12.49

1.3

10.37

13.93

u/l

2.28

115

621

Abnormalities of heart beat

145

748

1.93

12.48

1.3

1.2

10.01

14.56

u/l

4.32

124

702

Dermatitis

269

1673

1.61

12.46

1.3

14.44

13.74

u/l

0.25

247

1541

Certain disorders involving the immune mechanism

430

2.25

12.39

1.4

1.3

14.47

12.98

u/l

0.32

398

Malignant neoplasm of breast

173

678

1.85

12.34

1.2

1.3

11.29

11.57

u/l

0.09

161

611

Major coronary heart disease event

379

1682

1.51

12.25

1.3

12.96

13.85

u/l

0.22

338

1567

Nonischemic cardiomyopathy

123

3.46

12.22

1.3

18.09

12.61

u/l

0.19

114

Pain in limb

338

1595

1.54

12.10

1.3

11.90

14.44

u/l

1.89

313

1480

Injuries to the hip and thigh

249

1398

1.64

12.08

1.3

13.51

13.49

u/l

0.00

234

1283

Rheumatoid arthritis, including avohilmo

183

1037

1.77

12.07

1.3

19.38

12.34

u/l

4.27

173

947

Diabetic retinopathy, excluding more controls

132

364

2.06

12.03

1.3

13.26

13.79

u/l

0.05

114

344

Gastroduodenal ulcer

167

920

1.82

12.02

1.3

14.53

14.17

u/l

0.04

150

859

Malignant neoplasm of breast, HER2-negative

169

678

1.84

11.93

1.2

1.3

11.42

11.58

u/l

0.05

157

611

Stroke, including SAH

345

1683

1.52

11.88

1.3

10.56

13.71

u/l

4.02

309

1568

Mental and behavioural disorders due to alcohol

250

1506

1.62

11.81

1.3

14.88

14.79

u/l

0.01

234

1390

Multiple myeloma, excluding all cancers (controls excluding all cancers)

4.19

11.81

1.4

1.2

11.27

11.09

u/l

0.03

Seropositive rheumatoid arthritis, strict definition

333

2.39

11.76

1.3

21.68

11.86

u/l

3.41

304

Pain, not elsewhere classified

109

525

2.08

11.72

1.3

14.23

13.27

u/l

0.18

102

492

Multiple myeloma and malignant plasma cell neoplasms

4.14

11.61

1.4

1.2

11.27

10.97

u/l

0.04

Type 1 diabetes, wide definition

457

2.15

11.44

1.3

9.43

13.96

u/l

2.80

423

Other special examinations and investigations of persons without complaint or reported diagnosis

314

1017

1.57

11.43

1.3

12.49

14.44

u/l

1.13

284

958

Benign neoplasm: Colon

283

1783

1.56

11.40

1.4

1.3

10.68

13.83

u/l

2.39

263

1649

Misadventures to patients during surgical and medical care

320

2.39

11.36

1.4

1.3

13.25

13.22

u/l

0.00

294

Abnormal results of function studies

129

3.28

11.34

1.4

1.2

12.06

12.69

u/l

0.10

121

Other and unspecified dermatitis

218

1320

1.66

11.31

1.3

13.77

13.93

u/l

0.05

201

1214

Other disorders of skin and subcutaneous tissue, not elsewhere classified

358

2.31

11.30

1.4

1.3

10.77

12.91

u/l

0.71

328

In situ neoplasms

182

1051

1.74

11.28

1.2

1.3

13.23

13.42

u/l

0.04

170

953

Benign neoplasms

422

1619

1.46

11.24

1.3

14.43

14.72

u/l

0.05

392

1490

Type 1 diabetes

111

549

2.03

11.10

1.3

9.48

14.34

u/l

3.82

508

Hernia

405

1893

1.45

11.05

1.3

13.78

13.90

u/l

0.03

372

1746

Other disorders of glucose regulation and pancreatic internal secretion

168

2.94

11.02

1.4

1.2

17.07

12.69

u/l

0.20

157

Type 2 diabetes, definitions combined

401

1640

1.46

10.99

1.3

11.85

14.48

u/l

2.25

368

1521

Type 2 diabetes, strict (exclude DM1)

404

1656

1.46

10.97

1.3

11.76

14.43

u/l

2.33

371

1534

Symptoms and signs involving the digestive system and abdomen

453

1583

1.44

10.94

1.3

14.69

14.40

u/l

0.07

410

1474

Tuberculosis, IBD comorbidity

225

2.65

10.90

1.3

1.2

25.53

13.39

u/l

2.53

208

Respiratory tuberculosis

175

2.90

10.88

1.3

28.59

15.21

u/l

2.26

163

Respiratory tuberculosis, confirmed and not-confirmed

175

2.90

10.88

1.3

28.59

15.21

u/l

2.26

163

Other soft tissue disorders, not elsewhere classified

386

1628

1.47

10.87

1.3

12.46

14.63

u/l

1.54

355

1509

Tuberculosis

203

2.74

10.84

1.3

27.32

14.35

u/l

2.41

189

Other embolism and thrombosis

340

2.31

10.81

1.4

1.3

14.97

12.90

u/l

0.14

317

Other and unspecified polyneuropathies, also in other diseases

118

605

1.97

10.76

1.3

10.24

13.19

u/l

1.65

104

551

Coagulation defects, purpura and other haemorrhagic conditions

451

2.12

10.68

1.3

13.39

12.80

u/l

0.15

415

Other malignant neoplasms of skin (=non-melanoma skin cancer)

312

1633

1.51

10.64

1.3

15.04

12.69

u/l

0.89

293

1503

167

949

1.75

10.64

1.2

1.3

12.13

13.47

u/l

0.70

157

876

Alcohol use disorder, ICD-based

203

1230

1.66

10.56

1.3

15.53

15.03

u/l

0.07

190

1134

Syncope and collapse

211

1139

1.65

10.54

1.4

1.3

14.63

13.59

u/l

0.17

188

1071

Paralytic ileus and intestinal obstruction

142

782

1.82

10.38

1.3

15.67

13.11

u/l

0.38

131

726

Cellulitis

107

537

2.00

10.37

1.4

1.3

16.85

13.31

u/l

0.40

100

494

Autoimmune diseases related-to ILD

343

2058

1.47

10.32

1.3

17.73

13.45

u/l

0.91

307

1909

Intracranial trauma

226

1045

1.62

10.30

1.3

14.33

14.29

u/l

0.01

203

986

Finngen Rheumatological endpoints

393

1548

1.45

10.28

1.3

16.06

13.76

u/l

0.52

358

1433

Ischaemic Stroke, excluding all haemorrhages

318

1611

1.50

10.25

1.3

10.86

13.64

u/l

2.59

283

1503

Peripheral artery operations in Hilmo

420

2.14

10.19

1.3

9.81

14.85

u/l

2.27

387

Tuberculosis, wide

234

2.55

10.10

1.3

25.53

14.28

u/l

2.21

217

Intestinal stricture

165

958

1.73

10.10

1.3

14.99

13.81

u/l

0.17

151

878

Stroke, excluding SAH

328

1648

1.48

10.09

1.3

10.43

13.68

u/l

4.13

294

1537

Osteomyelitis

161

2.89

10.03

1.3

1.2

10.90

12.49

u/l

0.33

146

Supplementary factors related to causes of morbidity and mortality classified elsewhere

129

698

1.86

10.00

1.3

18.10

12.81

u/l

0.70

109

645

Type of accident

120

636

1.89

9.92

1.3

18.23

12.85

u/l

0.65

101

591

Amiodarone users

323

2.29

9.84

1.2

1.3

11.62

13.50

u/l

0.21

298

Other (not insulin) diabetes medications

412

1750

1.42

9.84

1.3

11.94

14.40

u/l

2.01

375

1622

Coronary revascularization (ANGIO or CABG)

265

1202

1.54

9.74

1.3

10.78

14.30

u/l

3.60

237

1113

Myocardial infarction, strict

262

1242

1.55

9.74

1.2

1.3

12.87

14.25

u/l

0.33

231

1150

Purpura and other haemorrhagic conditions

318

2.28

9.72

1.4

1.3

13.97

13.08

u/l

0.17

291

Cardiac arrest

3.42

9.72

1.2

8.76

16.80

u/l

3.46

Falls/tendency to fall

443

1578

1.41

9.66

1.3

13.30

14.41

u/l

0.43

396

1473

Asthma and opportunity respiratory infection

112

3.26

9.61

1.3

15.03

12.47

u/l

0.45

105

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

252

2.44

9.57

1.2

1.3

9.64

11.89

u/l

1.05

224

Parodontitis

385

2000

1.42

9.53

1.3

13.70

14.15

u/l

0.16

357

1840

Parodontitis or operation codes

385

2001

1.42

9.46

1.3

13.70

14.14

u/l

0.16

357

1841

Obesity related asthma

140

791

1.78

9.45

1.4

1.3

13.77

13.04

u/l

0.13

128

738

Basal cell carcinoma, including avohilmo

316

1699

1.47

9.40

1.3

15.10

12.59

u/l

0.99

296

1565

Melanocytic naevi

375

2.14

9.33

1.3

22.36

12.46

u/l

0.53

340

Gastric ulcer

109

573

1.91

9.29

1.3

13.21

13.31

u/l

0.01

528

Basal cell carcinoma

311

1692

1.47

9.27

1.3

15.16

12.63

u/l

0.98

291

1559

Other arthritis (FG)

135

762

1.78

9.16

1.4

1.3

15.60

13.02

u/l

0.72

128

711

Chronic periodontitis, including avohilmo

381

2001

1.41

9.09

1.3

13.75

14.15

u/l

0.14

353

1841

Benign neoplasm: Transverse colon

171

2.71

8.98

1.3

16.72

10.48

u/l

0.71

151

Presence of other functional implants

285

1358

1.49

8.98

1.3

12.37

14.04

u/l

0.46

259

1271

Left ventricular outflow tract obstruction (LVOTO), broad definition

177

2.67

8.95

1.4

1.3

14.88

12.40

u/l

0.25

168

Methotrexate

279

2.31

8.93

1.3

17.81

13.57

u/l

1.00

260

Type 2 diabetes, definitions combined, including avohilmo

390

1641

1.41

8.89

1.3

11.97

14.56

u/l

2.12

356

1519

Biguanides

409

1810

1.40

8.86

1.3

12.97

14.25

u/l

0.61

374

1674

Disorders of thyroid, IBD co-morbidities

226

2.27

8.81

1.4

1.1

12.29

12.74

u/l

0.11

217

Retention of urine

205

1098

1.59

8.78

1.3

12.90

14.27

u/l

0.54

192

1017

Systemic connective tissue disorders

154

914

1.69

8.76

1.3

13.75

12.31

u/l

0.65

137

840

Other symptoms and signs involving the urinary system

282

2.29

8.75

1.5

1.3

11.48

13.77

u/l

0.55

264

Benign neoplasm of other and ill-defined parts of digestive system

282

2.28

8.72

1.3

10.68

11.09

u/l

0.11

247

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

157

2.76

8.70

1.4

1.2

14.61

12.28

u/l

0.19

143

Osteoporosis

125

667

1.80

8.70

1.3

11.64

11.58

u/l

0.02

110

610

Viral infections characterized by skin and mucous membrane lesions

161

970

1.66

8.63

1.3

12.43

13.40

u/l

0.28

146

894

Zoster [herpes zoster]

462

1.98

8.63

1.3

10.13

12.39

u/l

1.15

421

Mycoses

121

677

1.80

8.50

1.3

12.55

12.80

u/l

0.07

103

625

Diagnoses used for exclusion with ILD

134

775

1.74

8.41

1.4

1.3

12.72

13.63

u/l

0.25

125

706

Malignant neoplasm of urinary organs

313

2.19

8.40

1.2

1.3

16.25

13.42

u/l

0.29

288

Persons encountering health services for other counselling and medical advice, not elsewhere classified

451

1893

1.36

8.31

1.3

13.41

14.35

u/l

0.27

424

1731

Asthma, including avohilmo

478

2065

1.35

8.29

1.3

13.91

14.13

u/l

0.06

430

1916

Diseases of peritoneum

245

2.35

8.26

1.2

1.3

10.74

13.46

u/l

0.69

225

Malignant neoplasm of kidney, except renal pelvis

271

2.27

8.21

1.2

1.3

17.04

13.95

u/l

0.29

252

Aortic valve malfunction, age under 60 years

162

2.67

8.21

1.4

1.3

15.73

12.45

u/l

0.31

154

Other specified/unspecified arthritis

119

670

1.78

8.20

1.4

1.3

16.24

13.34

u/l

0.72

113

626

Unspecified haematuria

226

1276

1.52

8.17

1.3

14.81

14.02

u/l

0.17

210

1180

Fracture of rib(s), sternum and thoracic spine

150

904

1.67

8.11

1.3

14.43

13.40

u/l

0.21

140

824

Chronic ulcer of skin, not elsewhere classified

181

2.57

8.08

1.4

1.3

9.40

14.91

u/l

1.41

167

Cutaneous abscess, furuncle and carbuncle

105

574

1.84

7.98

1.3

15.21

13.48

u/l

0.33

532

Colorectal cancer, excluding all cancers (controls excluding all cancers)

112

603

1.80

7.98

1.3

14.28

11.67

u/l

0.41

542

Thyrotoxicosis with toxic multinodular goitre

131

2.86

7.96

1.5

1.2

11.57

10.46

u/l

0.34

115

External causes of morbidity and mortality

269

910

1.48

7.84

1.4

1.3

13.58

14.76

u/l

0.26

247

855

Phlebitis and thrombophlebitis (not including DVT)

104

571

1.83

7.82

1.3

12.84

12.91

u/l

0.02

534

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

410

1.98

7.76

1.2

1.3

16.68

13.24

u/l

0.77

383

Emergency coronary revascularization (for ACS)

317

1613

1.42

7.75

1.3

10.91

14.03

u/l

3.37

286

1493

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

222

2.36

7.69

1.3

10.51

12.59

u/l

0.69

201

Factors influencing health status and contact with health services

133

382

1.75

7.58

1.2

12.84

15.58

u/l

0.78

122

364

Other or unspecified ileus, impaction or obstruction

100

549

1.83

7.53

1.2

1.3

16.97

12.18

u/l

0.56

504

Exposure to unspecified factor

377

2149

1.36

7.47

1.3

14.01

14.02

u/l

0.00

347

1983

Medical observation and evaluation for suspected diseases and conditions

287

1017

1.45

7.46

1.3

13.69

14.44

u/l

0.19

262

958

Elevated blood glucose level

171

2.53

7.41

1.2

1.3

14.68

11.72

u/l

0.55

158

Clear cell adenocarcinoma of kidney

121

2.85

7.29

1.2

1.3

10.28

12.79

u/l

0.57

112

Hypertensive Renal Disease

105

3.00

7.26

1.3

7.17

12.80

u/l

3.93

Diabetic retinopathy

174

696

1.59

7.18

1.3

12.42

12.56

u/l

0.02

151

643

General examination and investigation of persons without complaint and reported diagnosis

275

1014

1.45

7.18

1.3

15.51

14.46

u/l

0.13

246

955

Parodontitis and operation codes

349

1983

1.37

7.18

1.3

13.83

14.16

u/l

0.10

322

1824

Sleep disorders (combined)

400

1951

1.35

7.13

1.3

13.84

14.30

u/l

0.16

370

1799

Coronary artery bypass grafting

180

886

1.55

7.05

1.3

9.67

14.91

u/l

6.68

163

823

Injuries to the abdomen, lower back, lumbar spine and pelvis

168

1073

1.56

7.01

1.3

17.51

13.27

u/l

0.73

154

980

L02BA Anti-estrogens

257

2.19

7.00

1.3

1.2

10.88

11.12

u/l

0.06

231

Other external causes of accidental injury

340

1229

1.39

6.99

1.3

13.55

14.37

u/l

0.20

310

1145

Thyrotoxicosis

491

1.84

6.95

1.4

1.3

11.20

12.92

u/l

0.65

451

Fracture of lumbar spine and pelvis

108

622

1.74

6.94

1.3

18.01

12.46

u/l

0.63

568

Gastrointestinal diseases

202

662

1.53

6.90

1.3

12.54

14.24

u/l

0.69

184

618

Amputation of foot

3.40

6.87

1.1

1.2

13.05

14.21

u/l

0.08

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

417

1.90

6.77

1.2

1.3

10.59

11.31

u/l

0.29

376

Injuries to the thorax

207

1403

1.48

6.76

1.3

13.93

13.94

u/l

0.00

193

1284

Accidents

338

1229

1.38

6.73

1.3

12.95

14.37

u/l

0.43

309

1145

Benign neoplasm: Skin of other and unspecified parts of face

169

2.44

6.58

1.2

1.3

9.85

10.38

u/l

0.14

150

Other nutritional deficiencies

211

1414

1.46

6.49

1.3

14.83

14.46

u/l

0.06

194

1307

Diaphragmatic hernia

169

1112

1.53

6.41

1.3

12.55

12.79

u/l

0.08

156

1021

Suicide or other Intentional self-harm

418

1.87

6.40

1.2

1.3

16.87

12.95

u/l

0.89

388

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

440

1.85

6.37

1.2

1.3

16.68

13.04

u/l

0.84

409

Unspecified fall

201

1362

1.47

6.34

1.3

15.92

13.61

u/l

0.43

180

1256

Benign neoplasm: Ascending colon

385

1.91

6.33

1.6

1.3

8.01

13.13

u/l

3.47

351

Other gastritis (incl. Duodenitis)

110

656

1.68

6.30

1.5

1.3

10.49

13.72

u/l

2.32

608

Vascular disorders of the intestines

186

2.33

6.24

1.3

19.41

10.55

u/l

0.45

170

Sequelae of external causes of morbidity and mortality

111

666

1.67

6.22

1.4

1.3

11.65

13.32

u/l

0.52

612

Candidiasis

264

2.09

6.19

1.3

12.00

11.40

u/l

0.12

242

Sequelae of cerebrovascular disease

196

1172

1.47

6.19

1.3

10.42

14.16

u/l

3.82

178

1090

222

1460

1.44

6.18

1.2

1.3

12.89

12.83

u/l

0.02

206

1336

Degeneration of macula and posterior pole

249

1461

1.41

6.17

1.3

12.09

13.34

u/l

0.58

226

1348

Symptoms and signs concerning food and fluid intake

225

2.19

6.16

1.2

1.3

11.81

12.90

u/l

0.19

210

Other symptoms and signs involving the digestive system and abdomen

320

1.98

6.09

1.3

16.70

12.07

u/l

0.34

299

Concussion

178

1032

1.50

6.08

1.3

14.70

14.20

u/l

0.10

160

975

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

397

1.87

6.08

1.3

13.71

11.45

u/l

0.36

354

Thyrotoxicosis, other and/or unspecified

376

1.90

6.07

1.5

1.3

10.88

12.57

u/l

0.61

346

Lung diseases due to external agents

448

1.82

6.06

1.3

10.63

13.53

u/l

1.28

407

Pyogenic arthritis

164

2.40

6.04

1.2

1.3

10.35

14.23

u/l

0.72

150

Disorders of other endocrine glands

155

998

1.53

6.03

1.2

1.3

13.82

12.36

u/l

0.43

137

916

Delirium, not induced by alcohol and other psychoactive substances

364

1.91

5.98

1.1

1.3

11.02

12.64

u/l

0.43

329

Vascular diseases of the intestine

101

2.81

5.90

1.2

27.36

13.26

u/l

0.42

Intracranial injury

233

1602

1.41

5.90

1.3

14.21

14.03

u/l

0.04

208

1492

Genitourinary diseases

240

845

1.43

5.86

1.3

14.39

15.85

u/l

0.30

221

802

Actinic keratosis

209

1388

1.43

5.84

1.2

1.3

12.92

u/l

0.00

195

1269

Other other unspecified disorders of the circulatory system

3.04

5.82

1.2

7.25

13.63

u/l

1.58

Medicines for HER+ breast cancer

112

668

1.64

5.80

1.3

12.06

11.68

u/l

0.09

103

605

Sleep apnoea

371

1917

1.31

5.78

1.3

14.04

14.28

u/l

0.07

345

1766

Cholelithiasis, broad definition with cholecystitis

362

1885

1.32

5.75

1.3

13.38

13.54

u/l

0.03

331

1743

Diverticular disease of intestine

319

1580

1.34

5.75

1.3

13.80

13.63

u/l

0.04

296

1466

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

145

568

1.56

5.73

1.3

15.18

13.51

u/l

0.24

132

526

Persons encountering health services for examination and investigation

280

1017

1.38

5.73

1.3

14.09

14.44

u/l

0.08

256

958

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

145

559

1.56

5.67

1.3

15.19

13.49

u/l

0.24

132

518

Barrett oesophagus

115

2.64

5.65

1.3

11.16

13.49

u/l

0.43

107

Carcinoma in situ of skin of upper limb, including shoulder

4.12

5.65

1.1

1.2

10.40

12.78

u/l

0.39

Skin changes due to chronic exposure to nonionizing radiation

211

1408

1.42

5.65

1.2

1.3

12.90

12.89

u/l

0.00

197

1286

Small cell lung cancer, helper endpoint

2.98

5.60

1.1

1.3

12.21

12.72

u/l

0.06

Small cell lung cancer

2.98

5.60

1.1

1.3

12.21

12.72

u/l

0.06

Other viral diseases

480

1.75

5.59

1.3

13.46

13.96

u/l

0.12

446

Injury, poisoning and certain other consequences of external causes

212

736

1.45

5.59

1.3

13.99

15.20

u/l

0.21

195

689

Asthma, hospital admissions , main diagnosis only

306

2056

1.33

5.54

1.3

12.96

14.28

u/l

0.41

272

1904

Diabetic retinopathy, strict definition

442

1.74

5.52

1.3

8.90

13.16

u/l

2.96

412

Diseases of pulp and periapical tissues, including avohilmo

442

1793

1.28

5.47

1.3

14.17

13.59

u/l

0.18

412

1645

L02BG Aromatase inhibitors

562

1.68

5.40

1.2

1.3

12.10

11.38

u/l

0.17

507

Neurological diseases, wide definition

253

1.77

5.39

1.2

11.81

13.42

u/l

0.53

243

Missing teeth due to accident, extraction or parodontitis

287

1.96

5.34

1.4

1.3

14.35

13.28

u/l

0.16

267

Other necrotizing vasculopathies

174

2.26

5.33

1.4

1.3

12.18

11.51

u/l

0.13

160

Sub-endpoint used in defining T1D endpoints

123

776

1.56

5.30

1.3

9.45

13.61

u/l

3.63

102

712

Acute pancreatitis

550

1.68

5.30

1.3

19.27

13.56

u/l

0.49

510

Leiomyoma of uterus

263

1.78

5.30

1.2

12.23

12.18

u/l

0.01

225

Diseases of the eye and adnexa

280

1035

1.36

5.16

1.3

12.27

15.41

u/l

1.82

260

964

Dental operations

317

1225

1.33

5.16

1.3

14.16

13.03

u/l

0.32

289

1134

Multiple myeloma and malignant plasma cell neoplasms

127

2.47

5.14

1.4

1.2

11.27

12.30

u/l

0.15

119

Dental pulpitis 1

439

1799

1.27

5.06

1.3

14.19

13.60

u/l

0.18

409

1651

DVT of lower extremities

551

1.66

5.02

1.2

1.3

13.27

13.70

u/l

0.08

507

Leisure time condition

394

1.78

5.01

1.3

21.59

11.69

u/l

0.77

362

Abdominal and pelvic pain

403

1583

1.28

4.99

1.4

1.3

14.90

14.40

u/l

0.13

374

1474

Fitting and adjustment of other devices

154

978

1.47

4.95

1.4

1.3

11.88

13.64

u/l

0.92

147

904

Dental pulpitis 4

438

1800

1.27

4.94

1.3

14.13

13.60

u/l

0.16

408

1652

Alcohol dependence

123

804

1.53

4.93

1.3

16.82

14.55

u/l

0.26

116

742

Gastro-oesophageal reflux disease

262

1735

1.34

4.92

1.3

13.63

14.28

u/l

0.13

238

1610

Open wound of lower leg

296

1.90

4.90

1.2

1.3

13.27

11.80

u/l

0.50

273

Dermatitis and eczema

412

2134

1.27

4.90

1.3

13.79

14.09

u/l

0.12

383

1966

Benzodiazepine use

387

2164

1.27

4.88

1.3

14.65

13.83

u/l

0.23

355

1998

Coronary angioplasty

200

1099

1.40

4.85

1.3

11.90

14.43

u/l

1.55

176

1019

Atrial septal defect

3.48

4.84

1.6

1.1

10.25

12.02

u/l

0.24

Malignant neoplasm of breast, HER-positive

104

648

1.59

4.83

1.3

11.87

11.60

u/l

0.06

587

Chronic diseases of tonsils and adenoids

134

1257

0.67

4.82

1.3

16.84

13.94

u/l

0.22

125

1160

Examination and observation for other reasons

226

998

1.38

4.82

1.2

1.3

15.63

14.54

u/l

0.19

209

943

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

275

1.91

4.77

1.6

1.3

9.90

12.63

u/l

0.98

254

Other antidepressants

435

1804

1.26

4.74

1.3

14.77

13.85

u/l

0.28

403

1663

Use of anticholinesterases

1135

0.63

4.62

1.2

1.3

21.33

12.53

u/l

1.08

1032

N06DA Anticholinesterases

1135

0.63

4.62

1.2

1.3

21.33

12.53

u/l

1.08

1032

Other infectious diseases

192

2.10

4.61

1.5

1.3

23.42

13.99

u/l

0.79

180

Carbimazole or st.post thyroidectomy, condition for graves disease

361

1.78

4.58

1.4

1.3

12.03

11.85

u/l

0.05

328

Fracture of lower leg, including ankle

201

1458

1.38

4.57

1.3

14.87

14.34

u/l

0.10

183

1352

Angina pectoris

272

1392

1.32

4.52

1.4

1.3

12.37

14.03

u/l

0.46

247

1290

Other symptoms and signs involving cognitive functions and awareness

210

1447

1.36

4.50

1.3

14.33

13.40

u/l

0.24

193

1342

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

111

726

1.53

4.47

1.3

10.98

12.96

u/l

1.22

101

674

Disorders of parathyroid gland

531

1.62

4.46

1.2

1.3

12.32

12.40

u/l

0.02

487

Exposure to other specified factors

247

1746

1.33

4.46

1.3

16.70

14.08

u/l

0.52

236

1601

Use of disulfiram, acamprosate or naltrexone

136

2.29

4.44

1.4

1.3

12.16

11.92

u/l

0.06

130

Sequelae with surgical and medical care as external cause

532

1.62

4.41

1.4

1.3

11.69

12.67

u/l

0.24

488

Carcinoma in situ of other and unspecified sites

3.03

4.41

1.2

1.3

13.50

10.98

u/l

0.40

Superficial injury of head

509

1.64

4.40

1.2

1.3

19.90

12.68

u/l

0.61

476

Sleep apnoea, including avohilmo

377

1940

1.26

4.40

1.3

14.11

14.30

u/l

0.06

350

1789

Myocardial infarction, without ST-elevation

218

1493

1.35

4.39

1.3

12.35

13.69

u/l

0.27

190

1386

Other systemic involvement of connective tissue (FG)

101

646

1.56

4.37

1.2

1.3

14.82

12.02

u/l

1.03

597

Secondary malignant neoplasm of respiratory and digestive organs

3.58

4.36

1.1

1.2

10.00

12.43

u/l

0.68

Other specified/unspecified hearing loss

197

2.04

4.33

1.2

1.3

16.94

13.32

u/l

0.43

184

118

746

1.50

4.31

1.3

12.95

12.96

u/l

0.00

107

672

Selective deficiency of immunoglobulin G [IgG] subclasses

11.95

4.30

1.6

1.2

7.57

12.00

u/l

—

Dental caries 3 and operation codes

388

1581

1.26

4.30

1.3

14.63

13.10

u/l

0.54

356

1459

Carcinoma in situ, bladder

3.07

4.25

1.2

1.3

12.94

10.94

u/l

0.28

Benign neoplasm of bone and articular cartilage

2.70

4.25

1.4

1.2

28.71

9.90

u/l

1.16

Sulfonylureas

207

1220

1.36

4.24

1.3

11.98

13.50

u/l

0.49

184

1132

Other functional intestinal disorders

181

1251

1.38

4.22

1.2

1.3

15.17

13.15

u/l

0.33

152

1161

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

228

1.94

4.14

1.2

1.3

11.21

11.66

u/l

0.11

200

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

235

1.92

4.14

1.3

14.59

11.45

u/l

0.22

208

Any prescribed medicine buy

+∞

4.13

1.4

0.0

8.40

—

u/l

—

Dental caries 1 and operation codes

379

1548

1.26

4.13

1.3

14.12

13.04

u/l

0.36

348

1427

Squamous cell neoplasms and carcinomas of the skin

434

1.67

4.13

1.3

9.85

14.03

u/l

1.57

397

Benign neoplasm of urinary organs

3.00

4.12

1.4

1.2

16.35

10.88

u/l

0.54

162

1026

1.40

4.12

1.2

1.3

12.78

13.07

u/l

0.07

148

931

Aortic aneurysm

134

912

1.45

4.12

1.3

10.54

14.77

u/l

3.55

127

847

Obesity and other hyperalimentation

189

1376

1.36

4.08

1.3

13.05

14.59

u/l

0.58

175

1276

Open wound of ankle and foot

189

2.02

4.02

1.2

1.3

12.58

13.59

u/l

0.16

172

Acute pancreatitis (for exclusion)

593

1.56

4.01

1.3

19.27

13.08

u/l

0.55

545

Obesity

188

1373

1.36

4.01

1.3

13.05

14.61

u/l

0.59

174

1273

Cholelithiasis

335

1863

1.26

4.00

1.3

11.96

13.55

u/l

0.86

308

1723

Malignant melanoma

438

1.65

3.99

1.3

10.63

12.47

u/l

0.74

402

Noninfective enteritis and colitis

159

1141

1.39

3.99

1.3

21.48

12.88

u/l

0.81

139

1058

Acute upper respiratory infections of multiple and unspecified sites

249

1427

1.31

3.98

1.3

12.61

14.53

u/l

1.19

232

1308

Other hearing loss

143

992

1.42

3.98

1.3

13.90

13.53

u/l

0.09

125

914

Other condition

253

1.86

3.96

1.3

12.26

12.46

u/l

0.04

234

Dizziness and giddiness

295

1877

1.28

3.96

1.3

12.34

13.41

u/l

0.65

263

1743

Other systemic involvement of connective tissue

104

691

1.51

3.95

1.3

14.66

12.52

u/l

0.76

638

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

184

2.02

3.92

1.3

9.59

10.33

u/l

0.21

163

Sensorineural hearing loss

336

1871

1.26

3.92

1.3

13.52

13.71

u/l

0.06

302

1736

Vitreous haemorrhage

240

1.89

3.92

1.3

11.50

13.30

u/l

0.34

222

Conductive and sensorineural hearing loss

344

1902

1.25

3.89

1.3

13.33

13.68

u/l

0.13

311

1765

Smoking dependency

158

2.10

3.87

1.2

1.3

12.48

12.33

u/l

0.03

147

Congenital malformations, deformations and chromosomal abnormalities

161

1116

1.38

3.86

1.4

1.3

10.07

14.75

u/l

4.34

147

1034

Other disorders of ear

368

1973

1.24

3.86

1.3

12.97

14.13

u/l

0.56

331

1831

Mental and behavioural disorders due to tobacco

159

2.09

3.82

1.2

1.3

12.48

12.27

u/l

0.04

149

Other neurological diseases

312

1991

1.26

3.80

1.3

14.03

13.25

u/l

0.20

284

1842

Ulcer of oesophagus

201

1.95

3.77

1.3

1.2

10.72

13.06

u/l

0.65

184

Nonalcoholic fatty liver disease

140

2.15

3.76

1.4

1.3

9.60

10.72

u/l

0.50

127

Fracture of shoulder and upper arm

136

962

1.42

3.75

1.2

1.3

15.17

13.29

u/l

0.24

124

881

Dental caries 3

358

1466

1.25

3.75

1.3

14.42

12.97

u/l

0.50

330

1351

Fracture of foot, except ankle

447

1.61

3.70

1.3

12.84

14.19

u/l

0.29

414

Injuries to the ankle and foot

198

1357

1.33

3.69

1.3

13.20

15.15

u/l

0.78

172

1262

Other and unspecified immunodeficiencies with predominantly antibody defects

6.77

3.69

2.0

1.3

13.50

13.00

u/l

—

Psychiatric diseases

427

1749

1.22

3.68

1.3

16.64

13.67

u/l

0.91

400

1621

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

182

1.99

3.67

1.3

9.81

10.43

u/l

0.17

161

Chronic gastritis

127

893

1.43

3.65

1.3

15.64

13.71

u/l

0.22

114

825

Chronic laryngitis and laryngotracheitis

366

1.67

3.60

1.4

1.2

12.32

12.91

u/l

0.13

337

Pustulosis palmaris et plantaris

2.76

3.59

1.0

1.2

13.50

10.56

u/l

0.57

Corns and callosities

143

2.11

3.59

1.2

1.3

13.82

11.17

u/l

0.37

132

Benign neoplasm: Rectum, anus and anal canal

626

1.51

3.58

1.3

12.65

13.13

u/l

0.06

568

Other skin changes

460

1.59

3.56

1.2

1.3

9.38

12.40

u/l

1.68

420

Dental caries 1

347

1426

1.25

3.54

1.3

13.10

12.95

u/l

0.05

321

1311

Covid-19 suspected case

301

1.73

3.50

1.3

14.66

11.71

u/l

0.76

280

Benign neoplasm: Colon, unspecified

117

818

1.44

3.49

1.5

1.3

10.58

13.91

u/l

1.94

103

748

Exclusions for E4_PCOS_CONSORTIUM

180

838

1.35

3.48

1.2

1.3

12.03

12.29

u/l

0.11

164

768

Respiratory tuberculosis, not confirmed

132

2.14

3.46

1.3

1.2

27.09

15.83

u/l

0.88

121

Dental caries, including avohilmo

346

1427

1.24

3.44

1.3

13.11

12.95

u/l

0.06

320

1311

Obesity due to excess calories

135

972

1.39

3.41

1.4

1.3

12.65

13.46

u/l

0.28

125

902

Paracetamol of NSAID medication

227

1.62

3.41

1.2

1.3

13.19

15.02

u/l

0.22

208

Obesity, other/unspecified

634

1.49

3.38

1.4

1.3

13.56

13.54

u/l

0.00

586

Systemic sclerosis,strict definition

7.13

3.38

1.0

1.1

10.29

13.10

u/l

—

Parodontitis or/and operation codes

215

979

1.31

3.36

1.3

13.21

15.15

u/l

0.61

196

899

Benign neoplasm: Rectum

539

1.53

3.35

1.3

12.30

12.29

u/l

0.00

495

Sequelae of injuries, of poisoning and of other consequences of external causes

524

1.53

3.31

1.4

1.3

13.21

13.52

u/l

0.06

488

Fall on and from stairs and steps

614

1.49

3.28

1.3

18.47

12.95

u/l

0.50

566

Hyperparathyroidism

464

1.56

3.28

1.2

1.3

11.71

12.61

u/l

0.19

426

Triptan medication for migraine, single purchase ok

108

1039

0.70

3.26

1.3

12.90

13.86

u/l

0.26

103

964

Migraine, single triptan purchase ok & required. ICD-code if available is included

108

1039

0.70

3.26

1.3

12.90

13.86

u/l

0.26

103

964

Contact with and exposure to communicable diseases

344

1.65

3.26

1.2

1.3

13.16

14.22

u/l

0.16

322

Injury of unspecified body region

149

2.02

3.25

1.4

1.2

11.68

12.37

u/l

0.11

137

Other reaction to severe stress, and adjustment disorders

543

1.51

3.23

1.3

1.2

11.79

13.39

u/l

0.66

503

Disorders of skin appendages

138

1008

1.37

3.21

1.4

1.3

11.59

13.71

u/l

1.19

127

927

Secondary thrombocytopenia

5.41

3.20

1.1

1.2

12.88

12.87

u/l

—

Soft tissue disorders

384

1642

1.22

3.19

1.3

12.08

14.66

u/l

2.04

351

1521

Emotionally unstable personality disorder

2.27

3.19

1.4

1.3

15.00

12.07

u/l

0.42

Statin medication

228

997

1.28

3.11

1.3

11.91

15.74

u/l

1.92

207

930

Inflammatory diseases of the central nervous system

145

2.01

3.09

1.0

1.2

9.65

11.77

u/l

0.54

135

Inguinal hernia

261

1402

1.26

3.09

1.3

14.43

14.62

u/l

0.04

243

1300

Disorders of plasma-protein metabolism, not elsewhere classified

7.65

3.07

1.2

1.4

8.17

8.75

u/l

—

Exclusions for E4_PCOS_BROAD

321

1.65

3.06

1.2

1.3

15.00

12.38

u/l

0.32

297

Other diseases of pancreas

181

1.89

3.05

1.3

1.2

11.21

11.95

u/l

0.14

168

Hypoparathyroidism

2.60

3.05

1.2

13.56

10.54

u/l

0.48

Cholecystitis

408

1.57

3.03

1.3

21.14

13.60

u/l

0.52

376

Dermatophytosis

354

1.62

3.01

1.4

1.3

12.63

13.36

u/l

0.14

326

Childhood asthma (age<16), excluding more controls

6.17

3.00

1.3

1.2

10.14

12.22

u/l

—

Benign neoplasm: Connective and other soft tissue of thorax

10.27

3.00

1.0

7.60

9.80

u/l

—

Previous suicide attempt

10.11

2.98

1.6

1.2

8.40

7.60

u/l

—

Diseases of oral cavity, salivary glands and jaws

368

1561

1.21

2.95

1.3

14.83

13.32

u/l

0.49

334

1433

Other noninfective gastroenteritis and colitis

563

1.48

2.94

1.3

20.24

12.16

u/l

0.63

521

Arterial embolism and thrombosis

162

1.92

2.94

1.2

1.3

7.38

13.91

u/l

4.05

151

Retinal vascular disorders

380

1.59

2.93

1.3

9.74

12.73

u/l

1.21

343

Other and unspecified effects of external causes

467

1.52

2.93

1.3

14.78

12.18

u/l

0.66

434

Other diseases of anus and rectum

122

889

1.37

2.92

1.3

11.56

12.99

u/l

0.54

109

823

Transient ischemic attack

241

1595

1.25

2.91

1.3

14.14

13.48

u/l

0.13

216

1489

Disorders of eyelid, lacrimal system and orbit

321

2073

1.22

2.89

1.2

1.3

11.30

13.79

u/l

2.94

298

1910

Symptoms and signs involving the skin and subcutaneous tissue

240

1913

1.25

2.89

1.3

12.92

13.85

u/l

0.38

224

1763

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

6.78

2.88

1.2

1.1

12.17

6.89

u/l

—

Any mental disorder

431

1816

1.19

2.87

1.3

16.17

13.69

u/l

0.73

398

1683

Psoriasis

100

708

1.42

2.86

1.2

1.3

14.63

12.89

u/l

0.43

656

Focal epilepsy

528

1.48

2.82

1.2

1.3

11.90

12.66

u/l

0.23

483

Pustular psoriasis

2.35

2.82

1.0

1.2

13.54

10.64

u/l

0.63

Procreative management

356

1.54

2.79

1.2

15.10

12.87

u/l

0.51

332

Spondylopathies

327

1639

1.21

2.79

1.3

14.44

13.98

u/l

0.10

299

1519

Arthropathies

320

1337

1.22

2.78

1.3

13.78

13.94

u/l

0.04

295

1241

Diseases of the musculoskeletal system and connective tissue

182

702

1.30

2.76

1.3

1.2

13.27

15.13

u/l

0.59

169

660

Gingivitis and periodontal diseases

357

1532

1.20

2.75

1.3

16.07

13.30

u/l

0.99

328

1408

Maze procedure for atrial fibrillation

6.19

2.72

1.3

6.33

6.50

u/l

—

Schizophrenia or delusion, excluding more controls

577

1.45

2.72

1.3

15.28

12.85

u/l

0.81

530

Myeloid leukaemia

2.45

2.72

1.3

1.2

10.75

14.08

u/l

0.42

Dental pulpitis 2

305

1283

1.22

2.66

1.3

12.78

12.69

u/l

0.03

281

1176

Retinal vascular occlusion

374

1.56

2.66

1.2

1.3

9.85

12.77

u/l

1.15

338

Dental caries 1, only avohilmo

350

1492

1.20

2.63

1.3

14.39

12.88

u/l

0.51

322

1374

Injuries to unspecified part of trunk, limb or body region

198

1.77

2.63

1.4

1.3

10.90

12.42

u/l

0.35

180

Unstable angina pectoris

192

1256

1.27

2.61

1.4

1.3

12.60

13.92

u/l

0.26

169

1173

Opening and dilatation of root channel of tooth

2.26

2.60

1.4

1.2

8.56

10.27

u/l

0.46

Coeliac disease

222

1.72

2.56

1.4

1.3

10.12

12.15

u/l

0.65

208

Shoulder lesions

307

1557

1.21

2.56

1.3

13.22

14.39

u/l

0.55

274

1444

Disorders of continuity of bone

149

1.89

2.55

1.4

1.2

13.33

12.53

u/l

0.12

137

Spondyloarthritis

442

1.50

2.55

1.2

1.3

23.13

13.39

u/l

0.72

408

Embolic stroke with flimmer

2.44

2.54

1.3

1.2

8.10

13.09

u/l

—

Unspecific neurodegenerative disorder

137

1237

0.76

2.54

1.2

1.3

23.92

12.12

u/l

1.88

122

1130

Unspecified chronic bronchitis

2.17

2.51

1.6

1.3

11.00

13.76

u/l

0.47

Osteoporosis with pathological fracture (FG)

143

1.90

2.51

1.4

1.2

9.82

9.63

u/l

0.03

128

Neurological diseases

307

1279

1.21

2.50

1.3

13.40

13.90

u/l

0.12

277

1194

Cachexia

4.51

2.50

1.4

27.43

11.00

u/l

—

Fracture of skull and facial bones

477

1.47

2.50

1.2

1.3

15.30

13.06

u/l

0.49

447

Other diseases of liver

388

1.52

2.49

1.3

10.02

12.92

u/l

1.35

358

Dental operations, only avohilmo

318

1354

1.20

2.49

1.3

14.13

12.84

u/l

0.39

293

1246

Focal epilepsy, strict definition

494

1.46

2.48

1.2

1.3

12.18

12.84

u/l

0.18

452

Dental pulpitis 2, only avohilmo

311

1321

1.21

2.48

1.3

12.87

12.72

u/l

0.05

288

1211

Other and unspecified injuries of lower leg

103

2.05

2.41

1.4

1.2

9.00

11.86

u/l

1.23

Presbycusis

505

1.44

2.37

1.4

1.3

11.54

13.87

u/l

0.72

468

Assault by sharp object

4.15

2.36

1.0

1.1

16.71

11.18

u/l

—

Childhood asthma (age<16)

4.27

2.34

1.3

1.2

10.14

9.54

u/l

—

Urticaria and erythema

711

1.37

2.32

1.3

14.74

12.82

u/l

0.52

657

Juvenile osteochondrosis

3.23

2.31

1.1

14.11

11.43

u/l

—

Dental pulpitis 4, only avohilmo

420

1883

1.17

2.29

1.3

14.33

13.57

u/l

0.24

395

1727

Other crystal arthropathies

2.58

2.28

1.3

1.2

8.83

9.95

u/l

0.20

Mental disorders, not otherwise specified

2.07

2.27

1.1

1.3

11.79

11.39

u/l

0.08

Carcinoma in situ of skin of upper limb, including shoulder

2.30

2.25

1.1

1.2

10.40

15.44

u/l

0.71

Other interventions on the root canals of the tooth

3.92

2.25

1.6

1.2

6.43

13.33

u/l

—

Dementia in Alzheimer disease

624

0.66

2.25

1.3

21.27

12.28

u/l

0.51

568

Retinal detachments and breaks

149

1168

1.28

2.25

1.3

13.24

14.20

u/l

0.12

138

1079

Benign neoplasm: Connective and other soft tissue of thorax

5.70

2.23

1.0

1.3

7.60

12.00

u/l

—

Schizophrenia, schizotypal and delusional disorders

615

1.38

2.22

1.3

15.24

13.52

u/l

0.48

573

Disorders of ocular muscles, binocular movement, accommodation and refraction

127

968

1.30

2.22

1.3

11.95

13.73

u/l

0.77

114

896

Other disorders of veins

126

968

1.30

2.21

1.2

1.3

13.64

13.40

u/l

0.06

117

894

Nerve, nerve root and plexus disorders

396

2139

1.16

2.21

1.3

12.98

14.00

u/l

0.58

355

1983

Dental caries 3, only avohilmo

353

1534

1.18

2.21

1.3

14.73

13.08

u/l

0.57

323

1416

Coxarthrosis [arthrosis of hip](FG)

231

1373

1.22

2.20

1.3

12.50

13.56

u/l

0.44

215

1272

Psoriasis vulgaris

468

1.44

2.15

1.3

15.57

13.40

u/l

0.37

437

Disorders of sclera, cornea, iris and ciliary body

176

1416

1.24

2.15

1.3

13.60

14.53

u/l

0.23

160

1310

Eustachian salpingitis and obstruction

2.17

2.14

1.4

1.2

16.38

11.34

u/l

0.73

Weight loss

235

1.62

2.13

1.2

1.3

11.76

12.16

u/l

0.07

215

Cholera

2.11

2.13

1.1

1.3

10.76

10.30

u/l

0.06

Schizophrenia or delusion

612

1.37

2.12

1.3

15.28

13.49

u/l

0.49

570

Disorders of eyelid in diseases classified elsewhere

2.46

2.10

1.2

1.3

8.08

12.21

u/l

1.40

Acute sinusitis

141

1032

1.27

2.10

1.3

20.83

13.81

u/l

0.62

130

950

Iridocyclitis

555

1.39

2.08

1.3

13.28

13.09

u/l

0.03

514

Dental caries 2 and operation codes, only avohilmo

144

1130

0.79

2.06

1.3

17.79

14.85

u/l

0.45

136

1034

Use of memantine

938

0.73

2.06

1.3

20.82

12.84

u/l

0.70

856

Use of other anti-dementia drugs

938

0.73

2.06

1.3

20.82

12.84

u/l

0.70

856

Benign neoplasm: Skin of ear and external auricular canal

2.33

2.05

1.3

1.2

10.31

10.96

u/l

0.06

Agoraphobia

4.01

2.04

1.5

1.1

16.17

12.47

u/l

—

Other disorders of bone

366

1.48

2.04

1.3

15.36

12.83

u/l

0.48

340

Benign neoplasm: Skin of trunk

2.12

2.02

1.4

1.2

9.37

10.71

u/l

0.33

Other anxiety disorders

607

1.35

2.02

1.2

1.3

13.77

13.91

u/l

0.03

566

Injuries to the elbow and forearm

215

1606

1.21

2.02

1.2

1.3

16.03

13.47

u/l

0.50

192

1480

Acute epiglottitis

3.11

2.02

2.0

1.2

11.88

10.69

u/l

—

Benign neoplasm: Transverse colon

303

1.52

2.00

1.3

16.72

12.64

u/l

0.39

277

Pain (limb, back, neck, head abdominally)

293

1240

1.18

1.99

1.3

14.88

14.52

u/l

0.07

266

1158

Epilepsy

111

851

1.30

1.98

1.2

1.3

11.61

13.43

u/l

0.92

101

795

Hyperplasia of prostate

197

917

1.23

1.98

1.4

1.3

15.58

13.86

u/l

0.33

187

855

Injuries involving multiple body regions

2.29

1.98

1.5

1.2

20.77

11.00

u/l

0.32

Other disorders of lacrimal gland

108

828

1.31

1.97

1.2

1.3

10.93

13.01

u/l

1.18

100

765

Anterior Iridocyclitis

477

1.41

1.97

1.3

13.53

13.22

u/l

0.05

443

Dental pulpitis 1, only avohilmo

416

1890

1.15

1.96

1.3

14.44

13.54

u/l

0.30

391

1734

Crystal arthropathies, rheuma endpoint

2.38

1.96

1.2

8.83

11.04

u/l

0.43

Episodal and paroxysmal disorders

400

1779

1.15

1.95

1.3

14.95

14.08

u/l

0.26

355

1648

Hyperfunction of pituitary gland

2.36

1.95

1.1

1.2

13.67

11.67

u/l

0.34

Papulosquamous disorders

132

1041

1.27

1.95

1.2

1.3

15.50

13.29

u/l

0.71

115

968

Noninfectious colitis NAS

281

1.53

1.94

1.3

27.95

12.05

u/l

0.64

261

Dissocial personality disorder

3.78

1.94

1.5

1.1

22.67

9.00

u/l

—

Infections with a predominantly sexual mode of transmission

371

1.46

1.91

1.3

1.2

16.04

12.84

u/l

0.81

344

Other strabismus

371

1.45

1.90

1.3

14.10

12.12

u/l

0.42

347

Alzheimer disease, including avohilmo

117

1079

0.78

1.90

1.2

1.3

24.67

12.04

u/l

1.70

102

986

Acute and subacute iridocyclitis

448

1.41

1.88

1.2

1.3

13.58

13.34

u/l

0.04

418

Disorders of refraction and accommodation

438

1.41

1.87

1.3

9.05

12.29

u/l

2.52

407

Conjunctivitis (acute, non atopic)

540

1.37

1.86

1.4

1.3

17.13

13.57

u/l

0.30

495

Dorsalgia

360

1688

1.16

1.85

1.3

12.98

14.27

u/l

0.61

328

1565

Embolic stroke

159

1.71

1.85

1.2

1.3

11.45

14.79

u/l

0.50

149

Disorders of lacrimal system

136

1085

1.26

1.84

1.3

11.43

13.18

u/l

0.99

122

989

Injuries to the knee and lower leg

417

2091

1.14

1.84

1.3

13.38

14.16

u/l

0.30

378

1939

Other and unspecified disorders of vitreous body

1207

0.77

1.83

1.3

13.32

13.30

u/l

0.00

1108

Poisoning by narcotics and psychodysleptics [hallucinogens]

4.19

1.82

1.2

1.3

18.20

9.83

u/l

—

Malignant melanoma of skin

328

1.47

1.78

1.2

1.3

9.58

13.30

u/l

1.55

297

Hypothyroidism, strict autoimmune

245

1372

1.18

1.77

1.3

13.20

13.36

u/l

0.03

230

1276

Hernia of abdominal wall

169

1391

1.22

1.74

1.3

15.05

14.18

u/l

0.18

153

1285

Diabetic neuropathy

353

1.44

1.73

1.2

1.3

10.31

12.86

u/l

0.80

321

Burns and corrosions of multiple body regions

3.89

1.72

1.0

1.2

15.00

11.23

u/l

—

Benign neoplasm of other and ill-defined parts of digestive system

465

1.38

1.71

1.3

10.68

12.49

u/l

0.58

422

Perforation of tympanic membrane

218

1.56

1.70

1.2

1.3

12.83

11.58

u/l

0.27

200

Symptoms and signs involving the nervous and musculoskeletal systems

199

1667

1.19

1.70

1.3

14.19

13.72

u/l

0.07

178

1537

Abdominal aortic aneurysm (AAA)

437

1.39

1.69

1.2

1.3

10.73

15.25

u/l

1.63

401

Polycystic ovarian syndrome, consortium definition

145

705

1.24

1.69

1.3

1.2

11.99

11.85

u/l

0.04

126

644

Chondropathies

275

1.49

1.68

1.4

1.3

16.69

12.34

u/l

0.70

253

Diseases of external ear

113

899

1.26

1.61

1.3

16.15

13.56

u/l

0.28

103

822

Soft tissue disorders related to use, overuse and pressure

714

1.29

1.60

1.3

15.92

13.91

u/l

0.16

662

Alzheimer disease

102

973

0.79

1.59

1.2

1.3

25.92

12.09

u/l

1.57

888

Spinal stenosis

225

1500

1.18

1.59

1.3

12.10

13.51

u/l

0.83

204

1391

Traumatic subdural haemorrhage

447

1.37

1.59

1.5

1.3

12.52

13.05

u/l

0.13

419

Benign neoplasm: Skin of other and unspecified parts of face

279

1.47

1.58

1.2

1.3

9.85

11.64

u/l

0.62

254

Presence of other devices

759

1.28

1.58

1.3

11.09

13.88

u/l

1.66

702

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

172

1403

1.20

1.58

1.4

1.3

12.34

14.30

u/l

1.25

160

1294

Malignant neoplasm of digestive organs

176

1447

1.20

1.58

1.3

13.52

13.37

u/l

0.03

156

1338

Alzheimer’s disease, wide definition

830

0.76

1.55

1.2

1.3

22.45

12.10

u/l

1.04

763

Moderate visual impairment, binocular

1.94

1.54

1.1

1.2

12.60

13.44

u/l

0.09

Umbilical hernia

736

1.28

1.54

1.2

1.3

17.34

14.23

u/l

0.46

683

Complications of internal orthopaedic prosthetic devices, implants and grafts

666

1.29

1.54

1.4

1.3

11.49

13.27

u/l

0.65

610

Other disorders of Eustachian tube

2.28

1.53

1.4

1.2

10.00

11.31

u/l

—

Explicit fungal Sepsis

3.38

1.53

1.8

1.4

17.60

12.33

u/l

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.37

1.53

1.0

1.5

14.20

9.87

u/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

544

1.32

1.51

1.3

13.08

13.33

u/l

0.06

505

Prurigo nodularis

2.17

1.51

1.2

16.18

12.41

u/l

0.45

Myalgia

451

1.35

1.50

1.3

11.29

13.59

u/l

1.04

416

Dementia

151

1256

0.83

1.49

1.2

1.3

21.78

12.26

u/l

1.53

132

1152

Right hemicolectomy

170

1.60

1.49

1.2

1.3

10.30

12.41

u/l

0.48

158

Melanocytic naevi

618

1.30

1.47

1.3

22.36

12.69

u/l

0.51

569

Nontoxic diffuse goitre

2.13

1.44

1.4

1.1

9.18

10.74

u/l

0.45

Coxarthrosis

209

1209

1.17

1.44

1.3

12.26

13.39

u/l

0.47

196

1124

Fracture at wrist and hand level

770

1.26

1.43

1.3

14.79

14.41

u/l

0.05

707

Other and specified injuries of hip and thigh

2.19

1.40

1.3

1.2

10.30

11.22

u/l

—

Viral and other specified intestinal infections

256

1.45

1.39

1.4

1.2

13.74

13.43

u/l

0.04

241

Benign neoplasm: Kidney

1.90

1.39

1.4

1.2

16.93

11.26

u/l

0.46

Other surgical follow-up care

2.20

1.37

1.3

1.2

12.67

10.86

u/l

—

Other factor of the environment

2.96

1.36

1.4

1.2

10.20

10.35

u/l

—

Disorders of the thyroid gland

335

1941

1.13

1.35

1.3

12.78

13.93

u/l

0.36

308

1789

Functional dyspepsia

591

1.29

1.35

1.3

12.01

12.36

u/l

0.10

552

Cholecystectomy

252

1944

1.15

1.35

1.3

11.89

13.58

u/l

0.87

228

1801

Alzheimer’s disease (undefined)

0.00

1.35

0.0

1.3

—

16.55

—

Primary gonarthrosis, bilateral

156

1616

0.84

1.33

1.3

13.70

13.69

u/l

0.00

147

1489

Disorders of muscles

216

1.48

1.32

1.3

16.07

14.08

u/l

0.22

196

Other joint disorders

286

1337

1.14

1.31

1.3

14.46

13.94

u/l

0.15

259

1241

Alzheimer’s disease (Late onset)

790

0.78

1.31

1.2

1.3

22.45

12.10

u/l

0.98

726

Recurrent or chronic depression

570

0.76

1.31

1.2

1.3

14.20

14.52

u/l

0.06

523

Other blood glucose lowering drugs, excl. Insulins

515

1.30

1.31

1.3

11.52

13.14

u/l

0.49

473

Rare circulating lymphoid malignancy

1.85

1.30

1.6

1.2

10.43

14.24

u/l

0.64

Carcinoma in situ of other and unspecified genital organs

2.79

1.28

1.4

1.1

15.00

16.15

u/l

—

Intentional self-harm by sharp object

2.79

1.28

1.2

18.80

9.11

u/l

—

Use of donepezil

741

0.76

1.27

1.3

19.67

13.54

u/l

0.85

673

Demyelinating diseases of the central nervous system

1.72

1.27

1.2

35.47

10.82

u/l

0.52

Schizophrenia

285

1.41

1.27

1.2

1.3

14.09

13.10

u/l

0.26

266

Gonarthrosis, primary, with knee surgery

182

1729

0.86

1.25

1.3

11.81

13.72

u/l

1.44

172

1593

Superficial injury of lower leg

475

1.31

1.25

1.4

1.3

10.36

13.04

u/l

1.39

437

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

115

1.66

1.24

1.2

12.11

9.69

u/l

0.41

104

Juvenile arthritis (FINNGEN)

2.23

1.24

1.6

1.1

14.13

11.80

u/l

—

Impingement syndrome of shoulder

688

1.25

1.24

1.2

1.3

10.47

13.77

u/l

2.14

642

Postprocedural disorders of digestive system, not elsewhere classified

1.87

1.24

1.4

1.2

13.23

11.49

u/l

0.17

Paralytic ileus

100

1.71

1.23

1.4

1.2

36.12

10.85

u/l

0.63

Delivery, wide proxy

381

0.75

1.23

1.1

1.2

11.33

12.87

u/l

0.45

338

Liposarcoma

2.66

1.22

1.0

1.3

15.20

10.05

u/l

—

Varicose veins

238

1575

1.14

1.22

1.3

12.53

13.77

u/l

0.68

215

1461

Dyshidrosis [pompholyx]

2.64

1.22

1.2

9.20

12.05

u/l

—

Female genital prolapse

366

0.74

1.22

1.1

1.2

9.10

11.55

u/l

1.20

333

Acute upper respiratory infections

368

2073

1.11

1.19

1.3

13.79

13.80

u/l

0.00

339

1909

Acute generalized exanthematous pustulosis

1.84

1.19

1.7

1.2

9.31

11.81

u/l

0.45

Episcleritis

1.84

1.19

1.6

1.3

12.00

11.32

u/l

0.11

severe traumatic brain injury, does not include concussion

738

1.24

1.18

1.4

1.3

12.92

13.93

u/l

0.29

671

Superficial injury of ankle and foot

157

1.53

1.17

1.5

1.3

16.25

13.34

u/l

0.25

144

Convergent concomitant strabismus

1.93

1.17

1.5

1.1

15.91

12.02

u/l

0.32

Urolithiasis

1147

0.82

1.16

1.5

1.3

12.87

14.71

u/l

0.51

1059

Other diseases of urinary system

371

1880

1.11

1.16

1.3

13.41

13.86

u/l

0.16

342

1740

Dementia, including avohilmo

167

1339

0.86

1.15

1.2

1.3

20.65

12.20

u/l

1.49

147

1231

Low back pain

242

1642

1.14

1.15

1.3

13.39

14.15

u/l

0.23

220

1523

Anxiety (asthma-related co-morbidities)

128

847

1.19

1.14

1.2

1.3

13.96

14.78

u/l

0.19

115

788

Adverse effects, not elsewhere classified

326

1.35

1.13

1.4

1.3

12.64

11.98

u/l

0.11

302

Carcinoma in situ of other and unspecified sites

111

1.63

1.12

1.2

1.3

13.50

13.29

u/l

0.02

105

Psychotic depression

114

0.44

1.12

1.2

1.3

17.60

11.83

u/l

—

105

Erectile dysfunction

336

1.34

1.11

1.2

1.4

10.41

13.10

u/l

0.85

317

Allergic urticaria

119

1.60

1.11

1.3

1.1

16.21

12.65

u/l

0.39

109

Polymyalgia rheumatica

388

1.32

1.11

1.1

1.3

15.07

12.48

u/l

0.58

353

Acute bronchiolitis

2.00

1.11

1.1

1.3

13.50

11.78

u/l

—

Carcinoma in situ, bladder

104

1.64

1.09

1.2

1.3

12.94

13.23

u/l

0.03

Torticollis

2.39

1.09

2.0

1.2

8.40

8.95

u/l

—

Generalized skin eruption due to drugs and medicaments

1.82

1.09

1.8

1.2

9.75

12.32

u/l

0.42

Benign neoplasm of bone and articular cartilage

136

1.55

1.08

1.4

1.2

28.71

11.31

u/l

1.04

124

Diseases of inner ear

147

1674

0.86

1.07

1.3

12.46

13.70

u/l

0.51

135

1542

Seborrhoeic keratosis

657

1.23

1.07

1.3

12.85

13.27

u/l

0.07

602

Keratitis

101

839

1.21

1.06

1.3

13.77

13.16

u/l

0.10

771

Deep bite

108

0.49

1.06

1.2

1.3

23.00

10.67

u/l

—

Other disorders of eyelid

175

1472

1.15

1.05

1.2

1.3

10.87

13.26

u/l

1.71

162

1354

Abnormal serum enzyme levels

136

1148

1.17

1.04

1.3

12.43

14.74

u/l

0.94

117

1065

Dental caries 3 and operation codes, only avohilmo

445

0.80

1.03

1.3

11.38

13.24

u/l

0.59

408

Degenerative diseases of the nervous system

122

1081

0.85

1.03

1.2

1.3

23.54

12.08

u/l

1.60

108

987

Inflammatory bowel disease

715

1.22

1.03

1.4

1.3

21.09

12.92

u/l

0.44

663

Pregnancy, childbirth and the puerperium

339

0.77

1.00

1.3

1.2

8.59

11.92

u/l

2.31

302

Other specified/unspecified bacterial intestinal infections

131

1.53

0.99

1.5

1.2

12.70

12.72

u/l

0.00

120

Ventral hernia

664

1.22

0.99

1.3

12.68

13.16

u/l

0.11

607

Leiomyoma of uterus

138

671

1.17

0.99

1.2

11.30

11.72

u/l

0.16

125

609

Use of selegiline

134

0.52

0.98

1.1

1.3

16.14

12.85

u/l

—

123

Exposure to other and unspecified animate mechanical forces

2.18

0.98

1.0

1.2

5.80

12.39

u/l

—

Symptoms and signs involving speech and voice

104

875

1.19

0.98

1.4

1.3

12.53

13.14

u/l

0.20

801

Contusion of other and unspecified parts of foot

1.80

0.96

1.2

1.1

9.11

11.89

u/l

—

Papilloedema, unspecified

0.00

0.96

0.0

1.2

—

12.10

—

Gonarthrosis [arthrosis of knee](FG)

279

1477

1.11

0.95

1.3

13.27

13.56

u/l

0.10

255

1368

Follow-up examination after treatment for conditions other than malignant neoplasms

136

765

1.17

0.95

1.3

14.50

14.08

u/l

0.05

127

717

Other and unspecified urticaria

328

1.31

0.95

1.3

15.82

11.45

u/l

0.76

304

Diseases of salivary glands

434

1.27

0.95

1.2

1.3

12.87

12.72

u/l

0.03

403

Behavioural syndromes associated with physiological disturbances and physical factors

541

1.24

0.94

1.3

9.42

13.31

u/l

2.79

504

Myocardial infarction, with ST-elevation

687

1.21

0.94

1.3

11.38

13.95

u/l

0.74

624

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.62

0.93

1.3

1.2

8.87

9.93

u/l

0.25

Other and unspecified glaucoma

183

1.42

0.93

1.3

26.14

10.09

u/l

0.74

170

Diseases of male genital organs

223

1002

1.13

0.93

1.4

1.3

14.85

15.13

u/l

0.04

207

936

Strabismus

543

1.23

0.91

1.3

14.36

12.81

u/l

0.35

502

Unspecified mental disorder

102

864

1.18

0.90

1.2

1.3

15.48

12.93

u/l

0.66

804

Viral warts

151

1.46

0.90

1.4

1.3

10.65

12.21

u/l

0.28

137

Haemorrhoids and perianal venous thrombosis

110

938

1.17

0.90

1.2

1.3

13.11

13.07

u/l

0.01

873

Other disorders of the musculoskeletal system and connective tissue

349

1.29

0.90

1.2

1.3

15.47

13.12

u/l

0.34

321

Injuries to the shoulder and upper arm

287

2182

1.10

0.90

1.3

13.88

14.01

u/l

0.02

269

2007

Alzheimer’s disease, wide definition, excluding more controls

468

0.80

0.89

1.2

1.3

24.61

12.35

u/l

0.86

440

Fracture of forearm

154

1262

1.14

0.89

1.2

1.3

12.82

12.87

u/l

0.01

135

1165

L02BX Other hormone antagonists and related agents

218

0.64

0.89

1.8

1.3

10.36

14.16

u/l

0.83

202

Injury of muscle and tendon at shoulder and upper arm level

1154

0.85

0.88

1.2

1.3

13.15

13.79

u/l

0.16

1066

Visual disturbances and blindness

161

1416

1.14

0.88

1.2

1.3

10.65

13.95

u/l

2.92

143

1303

Other vitreous opacities

1.65

0.88

1.2

13.92

12.75

u/l

0.11

Ulcerative colitis

556

1.22

0.88

1.4

1.3

12.00

12.54

u/l

0.15

517

Melanocytic naevi of other and unspecified parts of face

1.79

0.87

1.6

1.2

14.60

9.49

u/l

—

All anxiety disorders

128

890

1.16

0.87

1.2

1.3

13.96

14.88

u/l

0.22

115

823

Colorectal cancer

794

1.19

0.87

1.3

15.19

13.54

u/l

0.19

720

Polyarthrosis

516

1.23

0.87

1.3

14.82

11.22

u/l

1.16

475

Other maltreatment syndromes

2.00

0.87

1.2

27.17

10.17

u/l

—

Inguinal of femoral hernia, unilateral

1.73

0.86

1.2

15.82

10.61

u/l

0.64

Inguinal hernia, unilateral

1.73

0.86

1.2

15.82

10.61

u/l

0.64

Femoral hernia, unilateral

1.73

0.86

1.2

15.82

10.61

u/l

0.64

Complications of genitourinary prosthetic devices, implants and grafts

1.83

0.86

1.3

1.2

11.13

18.03

u/l

—

Cervicobrachial syndrome

504

0.77

0.85

1.4

1.2

10.56

13.37

u/l

0.98

473

Female infertility

243

0.74

0.85

1.1

1.3

12.62

11.90

u/l

0.12

223

Benign neoplasm of urinary organs

112

1.52

0.85

1.4

1.2

16.35

13.17

u/l

0.26

103

Use of galantamine

239

0.67

0.84

1.1

1.3

9.81

13.88

u/l

0.92

218

Anankastic personality disorder

1.94

0.84

1.5

1.1

15.33

12.06

u/l

—

Other juvenile arthritis

1.94

0.84

1.8

1.1

15.33

11.84

u/l

—

Nontoxic multinodular goitre

478

1.24

0.84

1.2

1.3

11.23

12.82

u/l

0.54

435

Persistent mood disorders

425

1.25

0.83

1.3

13.17

11.86

u/l

0.28

392

Benign paroxysmal vertigo

788

0.82

1.5

1.3

11.67

12.37

u/l

0.19

720

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

561

1.21

0.82

1.4

1.3

14.75

13.43

u/l

0.17

520

Other specific arthropathies, wide

1.88

0.82

1.2

1.1

16.00

9.89

u/l

—

Hypothyroidism, other/unspecified

296

1783

1.10

0.81

1.3

12.78

13.89

u/l

0.30

272

1644

Acute alcohol intoxication

745

1.18

0.81

1.2

1.3

14.18

14.49

u/l

0.06

683

Kela-code for severe mental illness

782

1.18

0.81

1.2

1.3

15.86

13.07

u/l

0.66

725

Rotator cuff syndrome

224

1500

1.11

0.80

1.3

14.27

14.34

u/l

0.02

198

1388

Calculus of kidney and ureter

1023

0.85

0.80

1.5

1.3

11.41

14.10

u/l

1.28

939

Colorectal adenocarcinoma

664

1.19

0.79

1.2

1.3

10.59

13.63

u/l

1.60

603

Mood disorders

273

1966

0.91

0.79

1.2

1.3

15.60

14.08

u/l

0.41

256

1803

Hypothyreosis and Thyroxine purchase for inclusion criteria

306

1849

1.09

0.79

1.3

12.73

13.72

u/l

0.27

282

1706

0.00

0.78

0.0

1.1

—

11.15

—

Polyuria

693

1.18

0.78

1.4

1.3

14.18

13.94

u/l

0.04

631

Mood [affective] disorders

272

1959

0.91

0.77

1.2

1.3

15.62

14.12

u/l

0.40

255

1796

Postmenopausal osteoporosis with pathological fracture

115

1.48

0.76

1.4

1.3

9.17

10.46

u/l

0.21

Sleep disorders

394

1.24

0.76

1.4

1.3

8.57

13.40

u/l

2.86

363

Personal history of malignant neoplasm

1.70

0.75

1.6

1.1

10.78

11.15

u/l

—

Prolonged pregnancy

1.61

0.75

1.2

19.83

13.00

u/l

0.86

Urticaria

531

1.21

0.75

1.3

16.07

13.16

u/l

0.59

492

Injury of muscle and tendon at lower leg level

392

0.76

0.74

1.3

12.36

13.82

u/l

0.29

366

Coxibs

120

556

1.15

0.74

1.3

12.07

15.38

u/l

0.94

110

503

Alzheimer disease, excluding more controls

506

0.83

0.74

1.1

1.3

30.70

12.51

u/l

1.14

476

Carcinoma in situ of skin, other sites/unspecified

1.86

0.74

1.3

16.86

12.59

u/l

—

Benign neoplasm of brain and other parts of central nervous system

132

0.60

0.73

1.0

1.3

20.25

12.30

u/l

—

121

Encephalopathy

2.01

0.73

1.0

1.3

11.80

10.96

u/l

—

Scleritis and episcleritis

1.55

0.72

1.6

1.2

12.00

11.43

u/l

0.09

Gonarthrosis

243

1270

1.10

0.71

1.3

13.57

13.48

u/l

0.02

223

1180

Memory loss

282

1.28

0.71

1.4

1.3

16.06

12.11

u/l

0.51

258

Other enthesopathies

710

1.17

0.70

1.4

1.3

14.23

13.32

u/l

0.23

659

Otosclerosis

182

0.66

0.70

1.3

13.75

11.78

u/l

0.27

170

Malignant neoplasm of colon

472

1.21

0.70

1.2

1.3

14.43

11.97

u/l

0.29

427

Other congenital malformations of the digestive system

1.54

0.69

1.1

1.2

6.33

11.02

u/l

—

Other abnormal uterine and vaginal bleeding

350

1.20

0.67

1.4

1.2

11.33

11.67

u/l

0.06

320

Endometriosis of pelvic peritoneum

200

0.69

0.66

1.3

1.2

20.50

12.36

u/l

0.98

183

Arthrosis

256

1291

1.09

0.66

1.3

13.60

13.47

u/l

0.03

232

1199

Neuromuscular dysfunction of bladder

241

1.29

0.65

1.1

1.3

16.46

13.43

u/l

0.41

217

Non-selective monoamine reuptake inhibitors

129

1113

1.12

0.65

1.3

16.70

13.27

u/l

0.46

119

1016

Crohn's disease of large intestine

1.62

0.65

1.2

1.1

10.20

9.98

u/l

—

Malignant neoplasm of rectum

295

1.26

0.65

1.4

1.3

16.19

13.71

u/l

0.13

270

Combinations of oral blood glucose lowering drugs

103

906

1.14

0.63

1.3

10.04

14.76

u/l

4.05

838

Migraine without aura

181

1.33

0.63

1.4

1.3

15.71

10.90

u/l

1.34

173

MS-disease / Multiple Sclerosis

1.52

0.62

1.3

1.2

12.25

11.25

u/l

0.15

Paranoid personality disorder

1.67

0.61

1.4

1.2

18.00

10.83

u/l

—

Suppurative and unspecified otitis media

506

1.17

0.61

1.3

12.24

14.30

u/l

0.65

466

Other/unspecified dorsalgia

115

1016

1.13

0.61

1.4

1.3

14.66

13.81

u/l

0.17

108

942

Lateral epicondylitis

253

1.27

0.60

1.3

15.93

12.64

u/l

0.53

236

Glaucoma

222

1791

1.09

0.60

1.3

15.55

13.14

u/l

0.50

202

1655

Human immunodeficiency virus [HIV] disease

0.00

0.60

0.0

1.1

—

9.48

—

Benign neoplasm: Skin of lower limb, including hip

1.54

0.59

1.8

1.2

7.38

11.78

u/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

239

0.78

0.59

1.1

1.3

12.82

11.89

u/l

0.16

219

Menorrhagia

377

1.16

0.59

1.4

1.2

11.06

11.65

u/l

0.16

344

Migraine

663

0.86

0.58

1.3

12.31

12.32

u/l

0.00

628

Oxicams

542

0.87

0.58

1.2

1.3

12.12

15.01

u/l

0.74

490

Cluster headache, strict, including avohilmo

1.51

0.58

1.1

1.2

13.88

10.17

u/l

—

Tuberculosis of other organs

1.49

0.57

1.4

1.2

16.50

15.63

u/l

—

Any dementia

148

1151

0.91

0.56

1.2

1.3

20.59

12.39

u/l

1.22

128

1054

Viral infections of the central nervous system

115

1.39

0.56

1.1

1.2

11.81

11.34

u/l

0.05

102

Adenocarcinoma and papillary adenocarcinoma of stomach

0.58

0.56

1.2

1.3

13.80

13.22

u/l

—

Myocardial infarction, unclassifiable

109

866

1.12

0.56

1.2

1.3

12.52

13.80

u/l

0.24

789

Gestational diabetes (for exclusion)

171

0.74

0.56

1.3

1.2

14.33

13.69

u/l

0.07

161

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.54

0.55

1.3

1.2

8.00

12.66

u/l

—

Endometriosis ASRM stages 1,2

194

0.72

0.54

1.3

1.2

20.50

10.81

u/l

1.27

177

Benign neoplasm of other and unspecified sites

1.50

0.54

1.2

22.00

11.30

u/l

—

Blepharochalasis

880

1.13

0.54

1.2

1.3

10.22

12.81

u/l

1.66

801

Visual field defects

213

1.27

0.54

1.3

10.24

14.24

u/l

1.11

196

Fall on same level involving ice and snow

168

1538

1.09

0.53

1.3

12.91

13.90

u/l

0.40

148

1420

Injuries to the wrist and hand

304

2062

1.07

0.53

1.3

14.56

14.22

u/l

0.07

280

1907

Neurotic, stress-related and somatoform disorders

229

1509

1.08

0.52

1.2

1.3

13.14

14.51

u/l

0.59

208

1395

Noninflammatory disorders of female genital tract

384

0.86

0.52

1.2

13.02

11.99

u/l

0.28

351

Oral lichen ruber planus, including avohilmo

0.62

0.52

1.8

1.2

8.83

10.75

u/l

—

Tuberculosis of other organs, strict

1.41

0.51

1.3

1.2

16.33

14.93

u/l

—

Other specific joint derangements/joint disorders

202

1250

1.08

0.51

1.3

15.49

13.93

u/l

0.48

185

1159

Malignant neoplasm of stomach

157

0.70

0.51

1.3

1.2

12.82

14.99

u/l

0.18

144

Hypothyroidism, strict autoimmune, 3 medication purchases required

267

1700

1.07

0.50

1.3

13.13

13.72

u/l

0.13

252

1567

Myasthenia gravis

1.47

0.50

1.3

1.2

9.33

11.50

u/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

297

1.21

0.50

1.3

9.81

13.73

u/l

1.29

272

Any dementia, excluding more controls

139

1059

0.91

0.50

1.2

1.3

20.52

12.60

u/l

1.08

120

972

Disorders of vestibular function (Vertigo)

127

1388

0.91

0.49

1.4

1.3

12.52

13.01

u/l

0.15

117

1274

Organic, including symptomatic, mental disorders

215

1441

1.08

0.48

1.2

1.3

18.20

12.25

u/l

1.33

194

1331

Wet age-related macular degeneration

612

1.14

0.48

1.2

1.3

12.42

13.16

u/l

0.19

555

Amenorrhoea

1.52

0.48

1.1

1.3

9.14

10.50

u/l

—

Uterine polyps

166

0.72

0.47

1.3

8.92

11.30

u/l

0.58

153

Complications following abortion and ectopic and molar pregnancy

1.46

0.47

1.7

1.2

9.14

11.26

u/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

309

1.20

0.46

1.3

9.59

13.75

u/l

1.47

283

Redundant prepuce, phimosis and paraphimosis

539

1.15

0.46

1.4

1.3

18.00

14.91

u/l

0.40

501

All dysplastic lesions of the cervix uteri, vagina or vulva

262

1.21

0.46

1.1

1.2

12.04

11.56

u/l

0.09

239

Neuralgia and neuritis, unspecified

1.39

0.46

1.2

1.3

13.62

9.96

u/l

0.61

Other disorders of urethra and urinary system

228

1595

1.07

0.46

1.3

13.45

13.49

u/l

0.01

202

1475

Other dorsopathies, not elsewhere classified

339

1689

1.06

0.45

1.3

13.30

14.27

u/l

0.43

304

1565

Dental caries 2, only avohilmo

151

1294

0.92

0.45

1.3

17.52

14.46

u/l

0.51

143

1196

Single spontaneous delivery

423

0.88

0.45

1.2

10.25

13.22

u/l

1.47

380

Femoral hernia

112

1.34

0.44

1.3

13.47

12.93

u/l

0.05

102

Alzheimer’s disease (Late onset), excluding more controls

443

0.87

0.44

1.2

1.3

24.51

12.37

u/l

0.94

415

Appendectomy

163

1451

1.08

0.44

1.4

1.3

12.82

14.74

u/l

0.63

157

1339

Respiratory conditions due to other external agents

1.38

0.44

1.0

1.3

9.14

12.11

u/l

—

Follow-up care involving plastic surgery

1.37

0.44

1.3

1.2

9.00

9.69

u/l

—

Inflammatory diseases of prostate (prostatitis)

460

1.15

0.44

1.4

1.3

10.54

13.24

u/l

1.27

428

Transport accidents

119

962

1.10

0.43

1.3

21.80

15.07

u/l

0.69

110

895

Colectomy operation

498

1.15

0.43

1.2

1.3

10.54

12.30

u/l

0.64

457

Fenamates

310

0.85

0.43

1.5

1.3

11.79

13.37

u/l

0.28

276

Other orthopaedic follow-up care

1.38

0.42

1.2

1.1

12.17

10.06

u/l

0.39

Acetic acid derivatives and related substances

117

555

1.10

0.42

1.3

16.14

15.25

u/l

0.11

107

502

Type 1 diabetes, strict (exclude DM2)

1.38

0.41

1.0

1.2

9.00

15.29

u/l

1.15

Type 1 diabetes, definitions combined

1.38

0.41

1.0

1.1

9.00

15.35

u/l

1.17

Benign neoplasm: Eye, unspecified

0.00

0.41

0.0

1.3

—

10.07

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.52

0.41

1.2

36.20

13.00

u/l

—

Disorders of synovium and tendon

129

1263

0.92

0.41

1.4

1.3

13.25

13.91

u/l

0.20

115

1161

Premature separation of placenta [abruptio placentae]

0.00

0.41

0.0

1.1

—

11.73

—

Gonarthrosis,primary

312

2070

0.95

0.41

1.3

12.64

13.69

u/l

0.56

288

1905

Other intervertebral disc disorders

287

1660

1.06

0.41

1.3

13.93

14.07

u/l

0.04

254

1538

Vasomotor and allergic rhinitis

700

0.89

0.40

1.3

1.2

12.90

13.72

u/l

0.14

643

Causalgia

0.00

0.40

0.0

1.2

—

6.94

—

Patellar tendinitis

0.00

0.40

0.0

1.2

—

8.76

—

Headache

149

1152

1.08

0.40

1.3

13.17

13.98

u/l

0.22

138

1076

Melanocytic naevi of eyelid, including canthus

0.00

0.40

0.0

1.1

—

12.94

—

Anxiety disorders, excluding more controls

225

1401

1.06

0.39

1.2

1.3

12.93

13.92

u/l

0.41

205

1289

Mixed hyperlipidaemia

102

0.68

0.39

1.1

1.2

6.43

12.86

u/l

—

Other erythematous conditions

1.31

0.39

1.1

8.88

11.76

u/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.39

0.0

1.1

—

9.37

—

Other acquired deformities of musculoskeletal system and connective tissue

1.38

0.38

1.3

1.2

14.82

10.99

u/l

0.88

Postpartum hemorraghe, parous women as controls

132

1.26

0.38

1.2

14.68

12.66

u/l

0.33

122

Benign neoplasm: Anus and anal canal

1.35

0.38

1.4

1.2

14.22

11.20

u/l

—

Depression

246

1792

0.94

0.37

1.2

1.3

13.72

13.99

u/l

0.09

231

1640

Cholesteatoma of middle ear

147

0.75

0.37

1.2

1.3

11.64

12.60

u/l

0.12

134

Dislocation, sprain and strain of joints and ligaments of knee

123

1236

0.92

0.37

1.3

12.92

14.71

u/l

0.74

111

1153

Other degenerative diseases of the nervous system

100

693

1.09

0.37

1.1

1.3

27.68

12.77

u/l

1.36

655

Pregnancy hypertension

444

0.87

0.36

1.3

1.2

14.03

12.35

u/l

0.46

408

Chronic mastoiditis

1.27

0.36

1.2

13.78

13.55

u/l

—

malignant neoplasm of male genital organs

210

1256

1.06

0.35

1.4

1.3

14.41

14.50

u/l

0.02

192

1172

Delivery

423

0.90

0.35

1.2

10.30

13.22

u/l

1.46

380

Other diseases of gallbladder

1.32

0.35

1.5

1.1

9.62

12.35

u/l

0.48

Autonomic disorders

1.40

0.35

1.3

1.2

10.00

11.38

u/l

—

Diseases of the ear and mastoid process

386

1871

1.04

0.34

1.3

13.94

14.23

u/l

0.07

354

1737

Primary open-angle glaucoma, strict

100

918

1.09

0.34

1.2

1.3

15.38

12.60

u/l

0.29

830

Endometriosis of rectovaginal septum and vagina

133

0.75

0.33

1.0

1.2

12.60

11.84

u/l

—

122

Selective serotonin reuptake inhibitors

328

1805

0.96

0.32

1.2

1.3

16.59

13.85

u/l

0.91

307

1664

Anxiety disorders

231

1553

1.05

0.32

1.2

1.3

13.10

14.44

u/l

0.58

210

1434

Chorioretinal inflammation

1.28

0.32

1.2

24.67

10.60

u/l

—

Crushed, pushed or stepped on by crowd or human stampede

1.35

0.32

1.3

1.1

17.60

11.30

u/l

—

Other abnormal findings of blood chemistry

1.31

0.32

1.2

10.67

12.95

u/l

0.26

Benign neoplasm: Skin of ear and external auricular canal

101

1.29

0.31

1.3

1.2

10.31

13.46

u/l

0.34

Systemic atrophies primarily affecting the central nervous system

101

1.29

0.31

1.2

8.77

14.00

u/l

0.88

Lower back pain or/and sciatica

331

2200

1.04

0.31

1.3

13.22

14.02

u/l

0.32

302

2033

Primary open-angle glaucoma

126

1146

1.07

0.31

1.3

16.19

12.62

u/l

0.47

117

1049

Visual disturbances

135

1265

1.07

0.30

1.3

10.77

13.45

u/l

1.92

120

1167

Other diseases of upper respiratory tract

399

2002

1.04

0.30

1.3

12.66

13.84

u/l

0.51

372

1846

Endometriosis diagnosis and infertility diagnosis occurring together

1.31

0.30

1.1

1.2

13.55

12.54

u/l

0.11

Scar conditions and fibrosis of skin

1.25

0.29

1.3

1.1

11.00

11.81

u/l

—

Inflammatory disease of uterus

152

0.79

0.29

1.0

1.2

8.50

11.10

u/l

0.58

135

Progressive vascular leukoencephalopathy

109

0.73

0.29

1.3

1.2

14.00

16.86

u/l

—

Endometriosis

375

0.90

0.28

1.4

1.2

16.37

11.72

u/l

1.33

343

Medical treatment for female infertility

129

0.77

0.28

1.2

17.50

12.41

u/l

—

122

Cluster headache, wide,, including avohilmo

1.27

0.27

1.1

1.2

13.87

10.54

u/l

—

Diseases of middle ear and mastoid

131

1008

1.06

0.27

1.3

12.20

14.30

u/l

1.08

122

923

Cervicocranial syndrome

226

0.84

0.27

1.5

1.2

12.11

11.25

u/l

0.13

213

Other diseases of spinal cord

1.23

0.27

1.3

1.2

16.75

11.32

u/l

—

Voice disturbances

643

1.09

0.27

1.4

1.3

12.26

12.39

u/l

0.03

590

Atrophic disorders of skin

247

0.85

0.27

1.7

1.2

9.48

10.66

u/l

0.27

222

Injury of muscle and tendon at hip and thigh level

187

1.18

0.26

1.8

1.3

9.68

11.90

u/l

0.62

172

Nontoxic goitre/thyroid nodule

731

1.08

0.26

1.2

1.3

10.75

12.24

u/l

0.74

668

Cervical disc disorders

105

1121

0.94

0.26

1.3

12.23

14.11

u/l

0.76

1036

Colon adenocarcinoma

396

1.11

0.25

1.2

1.3

11.21

12.86

u/l

0.49

357

Other disorders of amniotic fluid and membranes

1.24

0.25

1.2

11.67

12.34

u/l

—

Struck by thrown, projected or falling objec

1.23

0.25

1.3

1.2

15.89

10.46

u/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

113

1062

1.06

0.25

1.3

15.83

13.55

u/l

0.24

977

Monoarthritis, not elsewhere classified

1.20

0.25

1.4

1.3

15.11

10.42

u/l

—

Postprocedural disorders of nervous system

1.20

0.25

1.1

1.2

17.44

11.72

u/l

—

Effects of foreign body entering through natural orifice

591

0.91

0.24

1.2

1.3

12.48

13.34

u/l

0.27

549

Other/unspecified synovitis and tenosynovitis

255

0.86

0.24

1.2

1.3

11.95

12.22

u/l

0.05

233

Mood disorders, excluding more controls

269

1701

0.96

0.24

1.2

1.3

15.67

13.73

u/l

0.55

252

1572

Lichen sclerosus et atrophicus

169

0.83

0.24

1.9

1.2

8.71

9.91

u/l

0.62

150

Disorders of breast

744

1.07

0.23

1.2

1.3

12.44

11.72

u/l

0.25

676

Glucosamine medication

173

1446

0.95

0.23

1.4

1.3

12.84

12.93

u/l

0.02

164

1323

Malignant neoplasm of prostate

207

1252

1.04

0.23

1.4

1.3

14.44

14.53

u/l

0.02

190

1167

Nonsuppurative otitis media

295

1.11

0.23

1.2

1.3

13.71

15.40

u/l

0.26

271

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

1.28

0.23

1.2

13.80

10.71

u/l

—

Deep endometriosis

125

0.80

0.23

1.0

1.3

12.60

9.83

u/l

—

109

Other bursopathies

342

1.11

0.22

1.3

15.00

13.45

u/l

0.23

315

Other diseases of hard tissues of teeth

177

1261

1.05

0.22

1.3

14.46

13.58

u/l

0.25

164

1157

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.27

0.22

1.3

8.00

11.77

u/l

—

Pain in joint

175

1108

1.05

0.21

1.3

16.15

14.79

u/l

0.32

159

1028

Idiopathic peripheral autonomic neuropathy

0.00

0.21

0.0

1.3

—

10.09

—

Senile degeneration of the brain, not elsewhere classified

0.00

0.21

0.0

1.3

—

11.36

—

Adrenogenital disorders

0.00

0.21

0.0

1.3

—

10.09

—

Factitial dermatitis

0.00

0.21

0.0

1.2

—

16.82

—

Other rupture of muscle

0.00

0.21

0.0

1.3

—

9.09

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.21

0.0

1.4

—

12.18

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.3

—

10.10

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.00

0.21

0.0

1.4

—

11.30

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.21

0.0

1.1

—

11.00

—

Striae atrophicae

0.00

0.21

0.0

1.3

—

10.00

—

Mandibular prognathia

0.00

0.21

0.0

1.2

—

11.10

—

Anxious personality disorder

0.00

0.21

0.0

1.2

—

10.50

—

Special screening examination for infectious and parasitic diseases

242

1.11

0.21

1.1

1.2

18.14

16.29

u/l

0.26

230

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.3

—

10.33

—

Other specified/unspecified diseases of inner ear

0.00

0.21

0.0

1.2

—

9.50

—

Frontotemporal dementia

0.00

0.21

0.0

1.3

—

14.75

—

Donors of organs and tissues

0.00

0.21

0.0

1.1

—

11.83

—

Cystitis

260

1646

0.97

0.21

1.3

12.87

13.84

u/l

0.39

245

1524

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.3

—

15.15

—

D07AA Corticosteroids, weak (group I)

239

1.13

0.20

1.2

1.3

12.81

12.16

u/l

0.14

221

Coxarthrosis, primary, with hip surgery

170

1681

0.96

0.20

1.4

1.3

12.51

13.12

u/l

0.20

159

1550

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

537

1.08

0.20

1.2

1.3

11.55

12.96

u/l

0.58

500

Sixth [abducent] nerve palsy

1.25

0.20

1.1

1.2

16.40

13.04

u/l

—

Disorders of other and unspecified cranial nerves

0.00

0.20

0.0

1.3

—

9.00

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.20

0.0

1.4

—

14.21

—

Other congenital malformations of upper alimentary tract

0.00

0.20

0.0

1.2

—

12.57

—

Frostbite

0.00

0.20

0.0

1.1

—

7.71

—

Specific development disorders of scholastic skills

0.00

0.20

0.0

1.3

—

16.36

—

Artificial joint operation, meniscal resection

327

2111

1.03

0.20

1.3

12.21

14.10

u/l

1.69

298

1951

Nontoxic single thyroid nodule

144

0.83

0.19

1.4

1.3

9.00

10.95

u/l

0.50

134

Nontraumatic intracranial haemmorrhage

674

1.07

0.19

1.3

10.77

14.28

u/l

1.57

620

Pedestrian injured in transport accident

133

0.83

0.19

1.5

1.2

32.64

11.30

u/l

0.61

122

Tooth eruption problems

1.22

0.19

1.3

1.2

24.64

13.84

u/l

0.30

Carpal tunnel syndrome

164

1541

0.96

0.19

1.3

11.83

13.88

u/l

1.28

150

1422

Oral leukoplakia, including avohilmo

1.13

0.18

1.3

1.2

16.00

11.59

u/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

208

0.88

0.18

1.2

1.3

13.32

12.65

u/l

0.07

191

Postpartum haemorrhage

144

1.15

0.18

1.2

14.68

13.92

u/l

0.10

132

Peripheral retinal degeneration

1.21

0.18

1.3

1.2

11.57

14.25

u/l

—

Foreign body entering into or through eye or natural orifice

147

1.16

0.18

1.4

1.3

12.42

12.76

u/l

0.05

138

Retinoschisis and retinal cysts

1.15

0.17

1.3

13.00

10.45

u/l

—

Other extrapyramidal and movement disorders in other diseases

610

1.07

0.17

1.3

13.73

13.02

u/l

0.15

558

Impacted cerumen

262

1.11

0.17

1.6

1.3

11.10

13.63

u/l

0.58

240

Speech therapy

708

1.06

0.17

1.5

1.3

14.23

12.79

u/l

0.25

651

Postpartum hemorraghe, all women as controls

166

1.14

0.17

1.2

14.68

13.76

u/l

0.12

152

Use of rasagiline

0.76

0.17

1.4

1.3

8.60

10.69

u/l

—

Malignant neoplasm of bladder

272

1.10

0.17

1.3

9.43

15.09

u/l

1.94

248

Total colectomy operation

0.78

0.15

1.0

1.2

17.00

11.43

u/l

—

Total colectomy

0.78

0.15

1.0

1.2

17.00

11.43

u/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

115

978

0.96

0.15

1.3

10.31

13.18

u/l

2.40

108

904

Other fall from one level to another

536

1.06

0.15

1.3

16.53

13.50

u/l

0.28

498

Radiculopathy

517

1.06

0.15

1.2

1.3

13.98

14.12

u/l

0.02

481

Hallux valgus (acquired)

653

0.95

0.15

1.3

13.06

11.87

u/l

0.31

601

Pregnancy with abortive outcome

126

633

1.04

0.14

1.3

1.2

11.23

11.73

u/l

0.18

116

576

Infections of genitourinary tract in pregnancy

1.18

0.14

1.5

1.2

9.45

11.75

u/l

0.52

Use of ropinirole

0.83

0.13

1.4

1.2

15.38

11.62

u/l

—

Irregular menses

453

1.06

0.13

1.4

1.2

12.06

12.72

u/l

0.20

419

Simple and mucopurulent chronic bronchitis

113

1.15

0.13

1.5

1.3

18.38

12.91

u/l

0.41

107

Meniscus derangement

185

1231

1.03

0.12

1.2

1.3

11.78

13.50

u/l

1.14

172

1142

Lesion of sciatic nerve

148

0.88

0.12

1.2

18.08

11.03

u/l

0.85

137

Internal derangement of knee

107

1029

1.04

0.12

1.3

1.2

12.91

14.07

u/l

0.22

952

Eating disorders

1.18

0.12

1.1

1.2

10.90

12.26

u/l

—

Lumbar disc prolapse

186

1517

0.97

0.12

1.3

12.98

14.15

u/l

0.43

168

1403

Maternal care for other conditions predominantly related to pregnancy

135

0.88

0.11

1.3

1.2

12.50

13.70

u/l

0.15

125

Dystonia

1.16

0.11

1.4

1.2

7.91

12.56

u/l

0.79

Dorsopathies

337

1689

1.02

0.11

1.3

13.52

14.27

u/l

0.32

303

1565

Disorders of vitreous body

147

1478

0.97

0.10

1.3

12.90

13.47

u/l

0.21

137

1354

Status post-ami

289

0.94

0.10

1.4

1.3

10.62

14.63

u/l

1.28

267

Vitamin B12 deficiency anaemia

309

1.07

0.10

1.5

1.3

8.81

12.38

u/l

1.57

286

Sciatica+with lumbago

136

1326

0.97

0.10

1.3

1.2

12.03

14.37

u/l

1.14

122

1225

Lesion of ulnar nerve

339

1.06

0.10

1.5

1.3

11.61

14.06

u/l

0.66

315

conjunctival degenerations and deposits

1.11

0.10

1.4

1.2

10.20

11.17

u/l

—

Abnormal involuntary movements

310

1.06

0.09

1.3

10.89

13.27

u/l

0.62

284

Disorders of conjunctiva

201

1718

0.98

0.09

1.3

15.26

14.23

u/l

0.19

186

1576

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.06

0.09

1.0

1.1

13.80

11.73

u/l

—

Adhesive capsulitis of shoulder

438

1.05

0.09

1.2

1.3

15.78

13.27

u/l

0.45

405

Diseases of appendix

199

1849

0.98

0.09

1.4

1.3

12.62

14.74

u/l

0.92

191

1700

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

165

0.91

0.08

1.3

8.87

11.98

u/l

0.86

150

Anti-inflammatory and antirheumatic products, non-steroids

114

557

1.03

0.08

1.2

1.3

13.06

15.39

u/l

0.44

105

504

Vertical strabismus

1.07

0.08

1.2

11.83

11.06

u/l

—

Other and unspecified erythematous conditions

1.05

0.08

1.2

9.33

12.00

u/l

—

Excessive attrition of teeth

493

0.97

0.08

1.3

14.15

14.28

u/l

0.02

452

Toxic effect of contact with venomous animals

1.03

0.08

1.2

10.83

u/l

—

Other disorders of breast

175

1.09

0.08

1.2

10.16

11.03

u/l

0.14

157

Excessive vomiting in pregnancy

0.82

0.08

1.4

1.3

10.20

12.60

u/l

—

Pedestrian injured in collision with pedal cycle

0.79

0.08

1.6

1.1

12.00

10.86

u/l

—

Left hemicolectomy

1.09

0.08

1.4

1.2

7.43

13.95

u/l

—

Benign neoplasm: Pancreas

1.09

0.08

1.1

1.2

9.86

11.86

u/l

—

Other specified/unspecified spondylopathies

1.09

0.08

1.4

1.2

7.43

12.80

u/l

—

Benign neoplasm: other/unspecified salivary gland

1.09

0.08

1.4

1.2

13.57

14.64

u/l

—

Central retinal artery occlusion

1.08

0.08

1.4

1.2

6.43

13.59

u/l

—

Hereditary corneal dystrophies

1.03

0.08

1.1

1.2

5.71

13.79

u/l

—

Migraine without aura and triptan purchases

127

1.10

0.07

1.4

1.2

13.43

11.78

u/l

0.33

115

Disturbances of smell and taste

0.86

0.07

1.2

7.17

9.92

u/l

—

Dislocation, sprain and strain of joint and ligaments of hip

0.80

0.07

1.2

8.00

14.07

u/l

—

Complications of labour and delivery

526

1.03

0.07

1.2

1.3

13.96

12.19

u/l

0.50

483

Flat foot [pes planus] (acquired)

176

1.08

0.07

1.2

1.3

16.58

10.95

u/l

0.60

158

Benign neoplasm of brain and other parts of central nervous system

1.05

0.07

1.0

1.3

20.25

9.91

u/l

—

Congenital malformations of eye, ear, face and neck

1.05

0.07

1.1

1.2

10.63

11.49

u/l

—

Other disorders of conjunctiva

392

1.05

0.07

1.5

1.3

12.83

12.85

u/l

0.00

359

Coxarthrosis, primary

226

1931

1.02

0.07

1.3

12.25

13.40

u/l

0.54

211

1781

Primary coxarthrosis, bilateral

1015

0.98

0.07

1.3

14.01

13.19

u/l

0.17

923

Dementia due to Parkinson's disease

0.84

0.07

1.3

1.2

10.00

13.67

u/l

—

Hordeolum and other deep inflammation of eyelid

0.85

0.07

1.3

1.2

13.29

11.43

u/l

—

Spondylosis

181

1525

1.02

0.07

1.3

12.96

14.09

u/l

0.46

170

1413

Striking against or struck by other objects

708

1.03

0.07

1.3

18.07

13.32

u/l

0.84

659

Dental caries 2

166

1328

0.98

0.07

1.3

16.74

14.51

u/l

0.38

157

1228

Deviated nasal septum

104

1015

1.02

0.07

1.4

1.3

14.71

14.22

u/l

0.08

938

Herpesviral keratitis and keratoconjunctivitis

1.12

0.07

1.3

1.2

29.00

14.17

u/l

—

Pterygium

0.86

0.06

1.0

1.2

25.75

13.16

u/l

—

Appendicitis, broad definition

198

1837

0.99

0.06

1.4

1.3

12.68

14.79

u/l

0.90

190

1689

Diabetes mellitus in pregnancy

132

0.93

0.06

1.3

1.2

12.79

12.64

u/l

0.02

123

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

500

1.03

0.06

1.3

1.2

12.39

12.54

u/l

0.04

462

Spontaneous rupture of synovium and tendon

188

1.06

0.05

1.2

1.3

16.70

12.24

u/l

0.66

170

Pedal cyclist injured in noncollision transport accidents

191

0.94

0.04

1.2

1.3

36.28

12.40

u/l

0.53

177

Stenosis and insufficiency of lacrimal passages

219

1.05

0.04

1.3

12.94

11.20

u/l

0.23

199

Allergic rhinitis

419

0.97

0.04

1.2

1.3

13.56

12.87

u/l

0.07

388

Persons encountering health services in circumstances related to reproduction

676

0.98

0.04

1.2

14.19

15.01

u/l

0.17

625

Foreign body or object entering through skin

101

1.09

0.04

1.2

13.18

11.25

u/l

0.48

Other noninflammatory disorders of vagina

121

1.07

0.03

1.7

1.2

7.23

10.25

u/l

1.36

109

Other arthrosis

169

1196

1.01

0.03

1.3

12.71

13.53

u/l

0.24

154

1108

Artrosis, including avohilmo

292

1614

0.99

0.03

1.3

14.21

14.24

u/l

0.01

268

1486

Glaucoma suspect

110

1115

0.99

0.03

1.3

16.30

12.80

u/l

0.40

1017

Spontaneous abortion

437

0.98

0.03

1.2

15.20

12.13

u/l

0.43

403

Inflammatory diseases of female pelvic organs

100

743

1.01

0.03

1.3

13.19

11.87

u/l

0.40

677

Acute appendicitis

185

1730

1.01

0.03

1.4

1.3

12.98

14.98

u/l

0.77

178

1590

Laparoscopic right hemicolectomy

148

0.95

0.02

1.3

1.2

10.00

12.40

u/l

0.72

136

Calculus of lower urinary tract

178

0.95

0.02

1.2

1.3

16.47

15.08

u/l

0.08

166

Spirochaetal infections, other/unspecified

182

1.04

0.02

1.2

1.3

13.74

12.14

u/l

0.20

166

Dental caries 2 and operation codes

162

1297

0.99

0.02

1.3

16.73

14.57

u/l

0.35

153

1200

Unspecified dementia

405

0.98

0.02

1.2

1.3

12.17

12.58

u/l

0.07

365

Medical abortion

115

619

1.01

0.02

1.3

1.2

10.43

11.68

u/l

0.67

107

564

Disorders of vitreous body and globe

158

1532

1.01

0.01

1.3

12.65

13.67

u/l

0.44

147

1403

Undefined dementia

398

1.02

0.01

1.2

1.3

12.17

13.89

u/l

0.32

361

Diplopia

324

1.02

0.00

1.2

1.3

11.56

13.17

u/l

0.31

299

Mouth breathing

111

1109

1.00

0.00

1.3

13.94

14.19

u/l

0.07

103

1028

Other noninflammatory disorders of uterus, except cervix

351

1.01

0.00

1.2

10.74

11.58

u/l

0.22

320

Depression or dysthymia

231

1291

1.00

0.00

1.3

12.76

13.61

u/l

0.37

219

1193

Extrapyramidal and movement disorders

119

1190

1.00

0.00

1.3

12.75

13.91

u/l

0.44

107

1094

Melanocytic naevi of other and unspecified parts of face

1.05

0.00

1.6

1.2

14.60

10.46

u/l

—

Superficial injury of shoulder and upper arm

232

0.99

0.00

1.5

1.3

16.39

12.19

u/l

0.47

211

Chalazion

238

1.01

0.00

1.5

1.3

11.75

12.51

u/l

0.13

218

Early lumbar disc prolapse, operated

1.03

0.00

1.2

21.80

12.59

u/l

—

Other disorders of eye and adnexa

249

1.00

0.00

1.2

1.3

12.05

11.18

u/l

0.14

230

Excessive, frequent and irregular menstruation

383

1.00

0.00

1.3

1.2

10.90

11.79

u/l

0.24

350

Conjunctivitis

167

1457

1.00

0.00

1.3

15.75

13.33

u/l

0.48

157

1336

Non-allergic asthma

195

1.03

0.00

1.3

9.67

12.01

u/l

0.59

181

Ovarian cyst

379

1.01

0.00

1.3

1.2

9.56

11.74

u/l

1.26

346

Alzheimer’s disease (Atypical or mixed), excluding more controls

272

1.02

0.00

1.2

1.3

26.68

12.99

u/l

0.47

260

Other/unspecified enthesopathies, not elsewhere classified

209

1.00

0.00

1.2

1.3

13.31

13.92

u/l

0.07

189

Other disorders of cornea

204

0.98

0.00

1.3

12.10

11.55

u/l

0.04

189

Alzheimer’s disease (Atypical or mixed)

325

1.01

0.00

1.2

1.3

26.68

11.93

u/l

0.52

295

Other disorders of nervous system

147

1.02

0.00

1.7

1.3

14.73

12.19

u/l

0.29

135

Vasomotor rhinitis (mode)

147

1.02

0.00

1.5

1.3

11.00

11.99

u/l

0.15

132

Other peripheral vertigo

223

0.99

0.00

1.3

15.68

11.23

u/l

0.50

207

Chromophobe cell carcinoma of kidney

0.00

0.0

1.3

—

12.11

—

Other and unspecified pemphigus

0.00

0.0

1.4

—

7.88

—

Benign neoplasm: Mediastinum

0.00

0.0

1.2

—

13.20

—

Rickettsioses

0.00

0.0

1.3

—

8.83

—

Venous complications and haemorrhoids in the puerperium

0.00

0.0

1.0

—

14.14

—

Migraine, unspecified, drug-induced

0.00

0.0

1.2

—

9.00

—

Other sudden death, cause unknown

0.00

0.0

1.4

—

8.38

—

Other cestode infections

0.00

0.0

1.2

—

15.17

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.3

—

9.33

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.0

1.2

—

13.60

—

Overjet

0.00

0.0

1.2

—

10.33

—

LSIL lesion of the vagina

0.00

0.0

1.0

—

18.25

—

Qualitative platelet defects

0.00

0.0

1.0

—

6.60

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.0

1.4

—

11.56

—

Explosion of other materials

0.00

0.0

1.6

—

7.20

—

Injury of blood vessels at lower leg level

0.00

0.0

1.1

—

11.13

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.0

1.2

—

17.67

—

Benign neoplasm: Penis

0.00

0.0

1.2

—

8.83

—

Benign neoplasm: Scrotum

0.00

0.0

1.2

—

9.78

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

0.0

1.6

—

7.80

—

Carcinoma in situ of larynx

0.00

0.0

1.4

—

11.40

—

Carcinoma in situ of oral cavity

0.00

0.0

1.3

—

14.33

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.4

—

15.20

—

Carcinoma in situ of vagina

0.00

0.0

1.0

—

19.00

—

Disorders of puberty, all

0.00

0.0

1.0

—

15.40

—

Other disorders of binocular vision

0.00

0.0

1.0

—

12.67

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.2

—

13.50

—

Anorexia (incl.atypical)

0.86

0.00

1.2

8.60

13.50

u/l

—

Disorders of adrenal gland, other and/or unspecified

0.00

0.0

1.1

—

9.00

—

Drug-induced obesity

0.00

0.0

1.3

—

8.43

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.0

1.3

—

8.43

—

Adult-onset Still disease

0.00

0.0

1.2

—

7.17

—

Disorders of tyrosine metabolism

0.00

0.0

1.4

—

12.40

—

Disorders of puberty

0.00

0.0

1.0

—

8.60

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.3

—

14.33

—

Bicipital tendinitis

0.91

0.00

1.1

1.3

13.75

12.32

u/l

—

Degenerative and vascular disorders of ear

0.00

0.0

1.2

—

9.80

—

Nonspecific lymphadenitis

0.96

0.00

1.9

1.2

9.25

11.04

u/l

—

Lesion of medial popliteal nerve

0.00

0.0

1.5

—

7.67

—

Congenital retinoschisis

0.00

0.0

1.2

—

7.40

—

Meningitis, viral

0.00

0.0

1.2

—

10.20

—

Allergic colitis

0.00

0.0

1.2

—

15.83

—

Abscess of tendon sheath

0.00

0.0

1.4

—

8.29

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

10.78

—

Lens-induced iridocyclitis

0.00

0.0

1.4

—

10.63

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

17.40

—

Adenocarcinoma of small intestine

0.00

0.0

1.4

—

11.78

—

Juvenile Open Angle Glaucoma

0.00

0.0

1.2

—

6.50

—

Acute inflammation of orbit

0.00

0.0

1.3

—

9.43

—

Unspecified pneumoconiosis

0.00

0.0

1.3

—

15.17

—

Other obstructive and reflux uropathy

0.92

0.00

1.4

1.2

8.71

13.73

u/l

—

Autism

0.00

0.0

1.2

—

8.83

—

Maxillary retrognathism

0.00

0.0

1.2

—

10.50

—

Traumatic subcutaneous emphysema

0.00

0.0

1.4

—

8.60

—

Wide developmental disorders

0.00

0.0

1.3

—

10.71

—

Autism spe

0.00

0.0

1.2

—

8.83

—

Generalized pustular psoriasis

0.00

0.0

1.6

—

8.57

—

Calcium deposit in bursa

0.00

0.0

1.2

—

10.67

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

1.4

—

7.60

—

Unspecified organic or symptomatic mental disorder

0.00

0.0

1.3

—

7.67

—

Mandibular hypoplasia

0.00

0.0

1.2

—

9.00

—

Traumatic spondylopathy

0.00

0.0

1.5

—

6.33

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.3

—

13.86

—

Other dermatomyositis

0.00

0.0

1.0

—

17.20

—

Small kidney of unknown cause

0.00

0.0

1.3

—

9.17

—

Benign neoplasm: Orbit, unspecified

0.00

0.0

1.1

—

14.00

—

Meningococcal infection

0.00

0.0

1.4

—

10.14

—

Toxic encephalopathy

0.00

0.0

1.2

—

14.33

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.3

—

8.56

—

Hypospadias

0.00

0.0

1.4

—

10.60

—

Enteritis due to Yersinia enterocolitica

0.00

0.0

1.3

—

13.50

—

Eccrine sweat disorders

0.00

0.0

1.2

—

7.80

—

Use of pergolide

0.00

0.0

1.5

—

8.17

—

Phantom limb syndrome with pain

0.00

0.0

1.3

—

5.33

—

Wide developmental disorders, excluding more controls

0.00

0.0

1.3

—

10.44

—

Other specified/unspecified inflammatory spondylopathies

0.97

0.00

1.0

1.3

6.67

11.25

u/l

—

Use of trihexyphenidyl

0.00

0.0

1.2

—

9.00

—

Autism spe, excluding more controls

0.00

0.0

1.3

—

10.71

—

Other congenital malformations of male genital organs

0.00

0.0

1.0

—

8.60

—

Benign neoplasm: Scrotum

0.00

0.0

1.1

—

12.43

—

Congenital malformations of breast

0.00

0.0

1.0

—

10.50

—

Other congenital malformations of kidney

0.00

0.0

1.0

—

16.60

—

Mastocytosis

0.00

0.0

1.5

—

13.83

—

Problems related to social environment

0.88

0.00

1.2

7.60

15.32

u/l

—

Marfan's syndrome

0.00

0.0

1.2

—

11.00

—

Other/unspecified disorders of vestibular function

0.96

0.00

1.4

1.2

6.13

11.59

u/l

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.0

1.2

—

7.60

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

0.0

1.3

—

14.43

—

Discharge from other and unspecified firearms

0.00

0.0

1.0

—

7.80

—

Contact with blunt object, undetermined intent

0.00

0.0

1.2

—

8.80

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.0

1.0

—

6.83

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.0

1.4

—

8.60

—

Drowning and submersion while in natural water

0.00

0.0

1.1

—

14.44

—

Sequelae of burns, corrosions and frostbite

0.00

0.0

1.3

—

12.71

—

Superficial frostbite

0.00

0.0

1.3

—

8.00

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.3

—

13.17

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.0

1.0

—

15.17

—

Injury of blood vessels at forearm level

0.00

0.0

1.7

—

7.83

—

Other injuries of spine and trunk, level unspecified

0.00

0.0

1.0

—

13.20

—

Vaginal lichen planus

0.00

0.0

1.0

—

17.67

—

Injury of blood vessels at neck level

0.00

0.0

1.3

—

15.57

—

Other and unspecified injuries of forearm

0.00

0.0

1.3

—

6.87

—

Neuroendocrine tumor and carcinoma of stomach

0.00

-0.00

0.0

1.1

—

11.88

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS